[Zurück]
 
Bitte auswählen
Jahr
Details
Sprache
Sortierung
Ausgabe
neu: RTF !
 Forschungsbericht alle Jahre

Wissenschaftliche Publikationen

Originalarbeiten in wissenschaftlichen Fachzeitschriften:
  • Blümle A, Sow D, Nothacker M, Schaefer C, Motschall E, Boeker M, Lang B, Kopp I, Meerpohl J: Manual systematische Recherche für Evidenzsynthesen und Leitlinien. Version 2.0 vom 01.04.2019 MANUAL SYSTEMATISCHE RECHERCHE FÜR EVIDENZSYNTHESEN UND LEITLINIEN, 2019; 2 (online): 1-63. : http://10.6094/UNIFR/149324 (download: https://freidok.uni-freiburg.de/fedora/objects/freidok:149324/datastreams/FILE1/content)
  • Deschler B, Ihorst G, Hull M, Baier P: Regeneration of older patients after oncologic surgery. A temporal trajectory of geriatric assessment and quality of life parameters. J Geriatr Oncol, 2019; 10 (1): 112-119. : http://dx.doi.org/10.1016/j.jgo.2018.09.010
  • Dittrich S, Graf E, Trollmann R, Neudorf U, Schara U, Heilmann A, von der Hagen M, Stiller B, Kirschner J, Pozza RD, Muller-Felber W, Weiss K, von Au K, Khalil M, Motz R, Korenke C, Lange M, Wilichowski E, Pattathu J, Ebinger F, Wiechmann N, Schroder R: Effect and safety of treatment with ACE-inhibitor Enalapril and beta-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial. Orphanet J Rare Dis, 2019; 14 (1): 105-105. : http://dx.doi.org/10.1186/s13023-019-1066-9
  • Kneis S, Wehrle A, Muller J, Maurer C, Ihorst G, Gollhofer A, Bertz H: It's never too late - balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: results of a randomized controlled trial. Bmc Cancer, 2019; 19 (1): 414-414. : http://dx.doi.org/10.1186/s12885-019-5522-7
  • Labonte V, Alsaid D, Lang B, Meerpohl JJ: Psychological and social consequences of non-invasive prenatal testing (NIPT): a scoping review. Bmc Pregnancy Childb, 2019; 19 (1): 385-385. : http://dx.doi.org/10.1186/s12884-019-2518-x
  • Lam AP, Matthies S, Graf E, Colla M, Jacob C, Sobanski E, Alm B, Rosler M, Retz W, Retz-Junginger P, Kis B, Abdel-Hamid M, Muller HHO, Lucke C, Huss M, Jans T, Berger M, Tebartz van Elst L, Philipsen A: Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial. JAMA Netw Open, 2019; 2 (5): e194980-e194980. : http://dx.doi.org/10.1001/jamanetworkopen.2019.4980
  • Langwitz S, Niemeyer P, Maurer J, Fritz J, Albrecht D, Angele P, Fickert S, Gelse K, Zinser W, Hofmann G, Spahn G: Degenerative Cartilage Lesions of the Medial Knee Compartment. Associated Factors, Operative Options, and Preliminary Results from the CartilageRegistry DGOU Z Orthop Unfallchir, 2019; 02: 115-20. : http://DOI: 10.1055/a-0820-6256 (download: https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-0820-6256.pdf)
  • Schorb E, Finke J, Ihorst G, Kasenda B, Fricker H, Illerhaus G: Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients. Bmc Cancer, 2019; 19 (1): 287-287. : http://dx.doi.org/10.1186/s12885-019-5473-z
  • Stomper J, Ihorst G, Suciu S, Sander PN, Becker H, Wijermans PW, Plass C, Weichenhan D, Bisse E, Claus R, Lubbert M: Fetal hemoglobin induction during decitabine treatment of elderly patients with Haematologica, 2019; 104 (1): 59-69. : http://dx.doi.org/10.3324/haematol.2017.187278
  • Unkel S, Amiri M, Benda N, Beyersmann J, Knoerzer D, Kupas K, Langer F, Leverkus F, Loos A, Ose C, Proctor T, Schmoor C, Schwenke C, Skipka G, Unnebrink K, Voss F, Friede T: On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies. Pharm Stat, 2019; 18 (2): 166-183. : http://dx.doi.org/10.1002/pst.1915
  • Voigt-Radloff S, Schopf AC, Boeker M, Frank L, Farin E, Kaier K, Korner M, Wollmann K, Lang B, Meerpohl JJ, Mohler R, Niebling W, Serong J, Lange R, van der Keylen P, Maun A: Well informed physician-patient communication in consultations on back pain study protocol of the cluster randomized GAP trial. Bmc Fam Pract, 2019; 20 (1): 33-33. : http://dx.doi.org/10.1186/s12875-019-0925-8
  • Bluhmki T, Schmoor C, Dobler D, Pauly M, Finke J, Schumacher M, Beyersmann J: A wild bootstrap approach for the Aalen-Johansen estimator. Biometrics, 2018; 74 (3): 977-985. : http://dx.doi.org/10.1111/biom.12861
  • Böhringer D, Grotejohann B, Ihorst G, Reinshagen H, Spierings R, Reinhard T, FANCY Studiengruppe: Rejection Prophylaxis in Corneal Transplant. A randomized study of HLA matching (the FANCY study). [Abstoßungsprophylaxe bei Hornhautübertragung]. Dtsch Arztebl Int, 2018; 115 (15): 259-265. : http://dx.doi.org/10.3238/arztebl.2018.0259
  • Coenen VA, Sajonz B, Reisert M, Bostroem J, Bewernick B, Urbach H, Jenkner C, Reinacher PC, Schlaepfer TE, Madler B: Tractography-assisted deep brain stimulation of the superolateral branch of the medial forebrain bundle (slMFB DBS) in major depression. Neuroimage-clin, 2018; 20: 580-593. : http://dx.doi.org/10.1016/j.nicl.2018.08.020
  • Deschler B, Ihorst G, Schnitzler S, Bertz H, Finke J: Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis. Bone Marrow Transpl, 2018; 53 (5): 565-575. : http://dx.doi.org/10.1038/s41409-017-0021-4
  • Duque-Afonso J, Ihorst G, Waterhouse M, Zeiser R, Wasch R, Bertz H, Muller-Quernheim J, Finke J, Marks R, Prasse A: Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning. Biol Blood Marrow Tr, 2018; 24 (11): 2277-2284. : http://dx.doi.org/10.1016/j.bbmt.2018.06.024
  • Engelhardt M, Herget GW, Graziani G, Ihorst G, Reinhardt H, Ajayi S, Knop S, Wasch R: Osteoprotective medication in the era of novel agents: a European perspective on values, risks and future solutions. Haematologica, 2018; 103 (5): 755-758. : http://dx.doi.org/10.3324/haematol.2018.188516
  • Geissler J, Jans T, Banaschewski T, Becker K, Renner T, Brandeis D, Dopfner M, Dose C, Hautmann C, Holtmann M, Jenkner C, Millenet S, Romanos M: Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)-Study protocol of a randomised controlled trial within the consortium ESCAlife. Trials, 2018; 19 (1) (online): 254-254. : http://dx.doi.org/10.1186/s13063-018-2635-2
  • Gengenbach L, Reinhardt H, Ihorst G, Ajayi S, Dold SM, Kohler M, Einsele H, Duyster J, Wasch R, Engelhardt M: Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials(). Leukemia Lymphoma, 2018; 59 (11): 2692-2699. : http://dx.doi.org/10.1080/10428194.2018.1448084
  • Greil C, Ihorst G, Kiote-Schmidt C, Hildenbeutel S, Kuhbach K, Bosse R, Duyster J, Engelhardt M, Wasch R: Stem cell mobilization in poor mobilizers with multiple myeloma or lymphoma before and after introduction of plerixafor: a single-center comparative analysis using a cost-efficient single fixed-dose schedule. Leukemia Lymphoma, 2018; 59 (7): 1722-1725. : http://dx.doi.org/10.1080/10428194.2017.1393673
  • Huss A, Ihorst G, Timme-Bronsert S, Hasenburg A, Oehler MK, Klar M: The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort. Ann Surg Oncol, 2018; 25 (13): 3966-3973. : http://dx.doi.org/10.1245/s10434-018-6756-3
  • Inzucchi SE, Zinman B, Fitchett D, Wanner C, Ferrannini E, Schumacher M, Schmoor C, Ohneberg K, Johansen OE, George JT, Hantel S, Bluhmki E, Lachin JM: How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care, 2018; 41 (2): 356-363. : http://dx.doi.org/10.2337/dc17-1096
  • Kaier K, Oettinger V, Reinecke H, Schmoor C, Frankenstein L, Vach W, Hehn P, von Zur Muehlen C, Bode C, Zehender M, Reinoehl J: Volume-outcome relationship in transcatheter aortic valve implantations in Germany 2008-2014: a secondary data analysis of electronic health records. Bmj Open, 2018; 8 (7): e020204-e020204. : http://dx.doi.org/10.1136/bmjopen-2017-020204
  • Kaier K, von Zur Muhlen C, Zirlik A, Schmoor C, Roth K, Bothe W, Hehn P, Reinohl J, Zehender M, Bode C, Stachon P: Sex-Specific Differences in Outcome of Transcatheter or Surgical Aortic Valve Replacement. Can J Cardiol, 2018; 34 (8): 992-998. : http://dx.doi.org/10.1016/j.cjca.2018.04.009
  • Krüger MT, Coenen VA, Jenkner C, Urbach H, Egger K, Reinacher PC: Combination of CT angiography and MRI in surgical planning of deep brain stimulation. Neuroradiology, 2018; 60 (11): 1151-1158. : http://dx.doi.org/10.1007/s00234-018-2079-0
  • Leinberger T, Heilmann C, Sorg S, Mueller M, Kueri S, Schmoor C, Siepe M, Beyersdorf F: The COSTA Study: Sternal Closure in High-Risk Patients - A Prospective Randomized Multicenter Trial. Thorac Cardiov Surg, 2018; 66 (6): 508-516. : http://dx.doi.org/10.1055/s-0037-1618584
  • Maccari ME, Abolhassani H, Aghamohammadi A, Aiuti A, Aleinikova O, Bangs C, Baris S, Barzaghi F, Baxendale H, Buckland M, Burns SO, Cancrini C, Cant A, Cathebras P, Cavazzana M, Chandra A, Conti F, Coulter T, Devlin LA, Edgar JDM, Faust S, Fischer A, Garcia-Prat M, Hammarstrom L, Heeg M, Jolles S, Karakoc-Aydiner E, Kindle G, Kiykim A, Kumararatne D, Grimbacher B, Longhurst H, Mahlaoui N, Milota T, Moreira F, Moshous D, Mukhina A, Neth O, Neven B, Nieters A, Olbrich P, Ozen A, Pachlopnik Schmid J, Picard C, Prader S, Rae W, Reichenbach J, Rusch S, Savic S, Scarselli A, Scheible R, Sediva A, Sharapova SO, Shcherbina A, Slatter M, Soler-Palacin P, Stanislas A, Suarez F, Tucci F, Uhlmann A, van Montfrans J, Warnatz K, Williams AP, Wood P, Kracker S, Condliffe AM, Ehl S: Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase delta Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase delta Syndrome Registry. Front Immunol, 2018; 9: 543-543. : http://dx.doi.org/10.3389/fimmu.2018.00543
  • Magnet FS, Bleichroth H, Huttmann SE, Callegari J, Schwarz SB, Schmoor C, Windisch W, Storre JH: Clinical evidence for respiratory insufficiency type II predicts weaning failure in long-term ventilated, tracheotomised patients: a retrospective analysis. J Intensive Care, 2018; 6: 67-67. : http://dx.doi.org/10.1186/s40560-018-0338-0
  • Marschner N, Wilke J, Reschke D, Kaiser F, Schmoor C, Grugel R, Boller E: A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10). J Med Econ, 2018; 21 (9): 920-929. : http://dx.doi.org/10.1080/13696998.2018.1484750
  • Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Muller TA, Hanke K, Taromi S, Apostolova P, Illert AL, Melchinger W, Duquesne S, Schmitt-Graeff A, Osswald L, Yan KL, Weber A, Tugues S, Spath S, Pfeifer D, Follo M, Claus R, Lubbert M, Rummelt C, Bertz H, Wasch R, Haag J, Schmidts A, Schultheiss M, Bettinger D, Thimme R, Ullrich E, Tanriver Y, Vuong GL, Arnold R, Hemmati P, Wolf D, Ditschkowski M, Jilg C, Wilhelm K, Leiber C, Gerull S, Halter J, Lengerke C, Pabst T, Schroeder T, Kobbe G, Rosler W, Doostkam S, Meckel S, Stabla K, Metzelder SK, Halbach S, Brummer T, Hu Z, Dengjel J, Hackanson B, Schmid C, Holtick U, Scheid C, Spyridonidis A, Stolzel F, Ordemann R, Muller LP, Sicre-de-Fontbrune F, Ihorst G, Kuball J, Ehlert JE, Feger D, Wagner EM, Cahn JY, Schnell J, Kuchenbauer F, Bunjes D, Chakraverty R, Richardson S, Gill S, Kroger N, Ayuk F, Vago L, Ciceri F, Muller AM, Kondo T, Teshima T, Klaeger S, Kuster B, Kim DDH, Weisdorf D, van der Velden W, Dorfel D, Bethge W, Hilgendorf I, Hochhaus A, Andrieux G, Borries M, Busch H, Magenau J, Reddy P, Labopin M, Antin JH, Henden AS, Hill GR, Kennedy GA, Bar M, Sarma A, McLornan D, Mufti G, Oran B, Rezvani K, Shah O, Negrin RS, Nagler A, Prinz M, Burchert A, Neubauer A, Beelen D, Mackensen A, von Bubnoff N, Herr W, Becher B, Socie G, Caligiuri MA, Ruggiero E, Bonini C, Hacker G, Duyster J, Finke J, Pearce E, Blazar BR, Zeiser R: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med, 2018; 24 (3): 282-291. : http://dx.doi.org/10.1038/nm.4484
  • Naegele M, Kirsch M, Ihorst G, Fierz K, Engelhardt M, De Geest S: Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study. Support Care Cancer, 2018; 26: 833-841. : http://dx.doi.org/10.1007/s00520-017-3897-z
  • Niglio de Figueiredo M, Krippeit L, Ihorst G, Sattel H, Bylund CL, Joos A, Bengel J, Lahmann C, Fritzsche K, Wuensch A: ComOn-Coaching: The effect of a varied number of coaching sessions on transfer into clinical practice following communication skills training in oncology: Results of a randomized controlled trial. Plos One, 2018; 13 (10) (online): e0205315-e0205315. : http://dx.doi.org/10.1371/journal.pone.0205315
  • Poguntke I, Schumacher M, Beyersmann J, Wolkewitz M: Simulation shows undesirable results for competing risks analysis with Bmc Med Res Methodol, 2018; 18 (1) (online): 79. : http://dx.doi.org/10.1186/s12874-018-0535-5
  • Reinacher PC, Amtage F, Rijntjes M, Piroth T, Prokop T, Jenkner C, Katzler J, Coenen VA: One Pass Thalamic and Subthalamic Stimulation for Patients with Tremor-Dominant Idiopathic Parkinson Syndrome (OPINION): Protocol for a Randomized, Active-Controlled, Double-Blinded Pilot Trial. JMIR Res Protoc, 2018; 7 (1): e36-e36. : http://dx.doi.org/10.2196/resprot.8341
  • Stiller B, Houmes RJ, Rueffer A, Kumpf M, Mueller A, Kipfmueller F, Koeditz H, Herber Jonat S, Schmoor C, Benk C, Tibboel D, Fleck T: Multicenter Experience With Mechanical Circulatory Support Using a New Diagonal Pump in 233 Children. Artif Organs, 2018; 42 (4): 377-385. : http://dx.doi.org/10.1111/aor.13016
  • Tinsel I, Siegel A, Schmoor C, Poguntke I, Maun A, Niebling W: Encouraging Self-Management in Cardiovascular Disease Prevention. A randomized controlled study of a structured advice and patient activation intervention in primary care Dtsch Arztebl Int, 2018; 115 (27-28): 469-476. : http://dx.doi.org/10.3238/arztebl.2018.0469
  • Tinsel I, Siegel A, Schmoor C, Poguntke I, Maun A, Niebling W: Förderung des Selbstmanagements zur Prävention von Herz-Kreislauf-Erkrankungen Dtsch Arztebl Int, 2018; 113 (27-28): 469-476.
  • von Bubnoff N, Ihorst G, Grishina O, Rothling N, Bertz H, Duyster J, Finke J, Zeiser R: Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628). Bmc Cancer, 2018; 18 (1) (online): 1132-1132. : http://dx.doi.org/10.1186/s12885-018-5045-7
  • Waldschmidt JM, Keller A, Ihorst G, Grishina O, Muller S, Wider D, Frey AV, King K, Simon R, May A, Tassone P, Duyster J, Jung M, Raje N, Wasch R, Engelhardt M: Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma). Haematologica, 2018; 103 (10): e473-e479. : http://dx.doi.org/10.3324/haematol.2018.189969
  • Weis J, Honig K, Bergelt C, Faller H, Brechtel A, Hornemann B, Stein B, Teufel M, Goerling U, Erim Y, Geiser F, Niecke A, Senf B, Wickert M, Schmoor C, Gerlach A, Schellberg D, Buttner-Teleaga A, Schieber K: Psychosocial distress and utilization of professional psychological care in cancer patients: An observational study in National Comprehensive Cancer Centers (CCCs) in Germany. Psycho-oncol, 2018; 27 (12): 2847-2854. : http://dx.doi.org/10.1002/pon.4901
  • Windisch W, Schwarz SB, Magnet FS, Dreher M, Schmoor C, Storre JH, Knipel V: Using web-based videos to improve inhalation technique in COPD patients requiring hospitalization: A randomized controlled trial. Plos One, 2018; 13 (10) (online): e0201188-e0201188. : http://dx.doi.org/10.1371/journal.pone.0201188
  • Zinnow T, Banaschewski T, Fallgatter AJ, Jenkner C, Millenet S, Philipsen A, Retz W, Sobanski E, Thome J, Rösler M: ESCAlate – Ein adaptiver Behandlungsansatz für Jugendliche und Erwachsene mit ADHS Z Psychiatr Psych Ps, 2018; 66: 219-231. : https://doi.org/10.1024/1661-4747/a000360
  • Zinnow T, Banaschewski T, Fallgatter AJ, Jenkner C, Philipp-Wiegmann F, Philipsen A, Retz W, Sobanski E, Thome J, Rosler M: ESCAlate - Adaptive treatment approach for adolescents and adults with ADHD: study protocol for a randomized controlled trial. Trials, 2018; 19 (1) (online): 280-280. : http://dx.doi.org/10.1186/s13063-018-2665-9
  • Andrlovà H, Mastroianni J, Madl J, Kern JS, Melchinger W, Dierbach H, Wernet F, Follo M, Technau-Hafsi K, Has C, Rao Mittapalli V, Idzko M, Herr R, Brummer T, Ungefroren H, Busch H, Boerries M, Narr A, Ihorst G, Vennin C, Schmitt-Graeff A, Minguet S, Timpson P, Duyster J, Meiss F, Roemer W, Zeiser R: Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-beta1 expression. Oncotarget, 2017; 8 (26): 42901-42916. : http://dx.doi.org/10.18632/oncotarget.17160
  • Doepfner M, Hautmann C, Dose C, Banaschewski T, Becker K, Brandeis D, Holtmann M, Jans T, Jenkner C, Millenet S, Renner T, Romanos M, von Wirth E: ESCAschool study: trial protocol of an adaptive treatment approach for school-age children with ADHD including two randomised trials. Bmc Psychiatry, 2017; 17 (1): 269-269. : http://dx.doi.org/10.1186/s12888-017-1433-9
  • Duiverman ML, Maagh P, Magnet FS, Schmoor C, Arellano-Maric MP, Meissner A, Storre JH, Wijkstra PJ, Windisch W, Callegari J: Impact of High-Intensity-NIV on the heart in stable COPD: a randomised cross-over pilot study. Resp Res, 2017; 18 (1): 76-76. : http://dx.doi.org/10.1186/s12931-017-0542-9
  • Engelhardt M, Domm AS, Dold SM, Ihorst G, Reinhardt H, Zober A, Hieke S, Baayen C, Mueller SJ, Einsele H, Sonneveld P, Landgren O, Schumacher M, Waesch R: A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients. Haematologica, 2017; 102 (5): 910-921. : http://dx.doi.org/10.3324/haematol.2016.162693
  • Engelhardt M, Selder R, Pandurevic M, Moeller M, Ihorst G, Waldschmidt J, Herget G, Waesch R: [Multidisciplinary Tumor Boards: Facts and Satisfaction Analysis of an Indispensable Comprehensive Cancer Center Instrument]. Deut Med Wochenschr, 2017; 142 (9): e51-e60. : http://dx.doi.org/10.1055/s-0043-100054
  • Finke J, Schmoor C, Bethge WA, Ottinger H, Stelljes M, Volin L, Heim D, Bertz H, Grishina O, Socie G: Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial. Lancet Haematol, 2017; 4 (6): e293-e301. : http://dx.doi.org/10.1016/S2352-3026(17)30081-9
  • Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Moehle R, Loew S, Binder M, Atta J, Keller U, Wolf HH, Krause SW, Hess G, Naumann R, Sasse S, Hirt C, Lamprecht M, Martens U, Morgner A, Panse J, Frickhofen N, Roeth A, Hader C, Deckert M, Fricker H, Ihorst G, Finke J, Illerhaus G: High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). Leukemia, 2017; 31 (4): 846-852. : http://dx.doi.org/10.1038/leu.2016.334
  • Greil C, Ihorst G, Gaiser F, Salzer U, Bisse E, Kastritis E, Ludwig H, Waesch R, Engelhardt M: The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies. Eur J Haematol, 2017; 99 (5): 449-458. : http://dx.doi.org/10.1111/ejh.12958
  • Greil C, Kiote-Schmidt C, Fink G, Ihorst G, Hildenbeutel S, Bosse R, Duyster J, Engelhardt M, Waesch R: Successful peripheral blood stem cell mobilization with a cost-efficient single fixed-dose plerixafor schedule in poor mobilizers. Leuk Lymphoma, 2017; 58 (8): 1849-1858. : http://dx.doi.org/10.1080/10428194.2016.1271946
  • Grohmann J, Wildberg C, Zartner P, Abu-Tair T, Tarusinov G, Kitzmueller E, Schmoor C, Stiller B, Kampmann C: Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients. Catheter Cardio Inte, 2017; 89 (7): E226-E232. : http://dx.doi.org/10.1002/ccd.26881
  • Gross V, Lucke C, Graf E, Lam AP, Matthies S, Borel P, Sobanski E, Rosler M, Retz W, Jacob C, Colla M, Huss M, Jans T, Kis B, Abdel-Hamid M, Tebartz van Elst L, Philipsen A: Effectiveness of Psychotherapy in Adult ADHD: What Do Patients Think? Results of the COMPAS Study. J Atten Disord, 2017: 1087054717720718-1087054717720718. : http://dx.doi.org/10.1177/1087054717720718 (in Druck)
  • Hiller JK, Schmoor C, Gaidzik VI, Schmidt-Salzmann C, Yalcin A, Abdelkarim M, Blagitko-Dorfs N, Doehner K, Bullinger L, Duyster J, Luebbert M, Hackanson B: Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy. Ann Hematol, 2017; 96 (4): 559-565. : http://dx.doi.org/10.1007/s00277-016-2912-7
  • Jenkner C, Mueller-Rath R, Miltner O, Niemeyer P: Große Zahlen = Große Aussagen? Was können Registerdaten für den klinischen Alltag leisten? Sports Orthopaedics and Traumatology, 2017; 33 (2): 142-147.
  • Kaier K, Reinecke H, Schmoor C, Frankenstein L, Vach W, Hehn P, Zirlik A, Bode C, Zehender M, Reinoehl J: Learning Curves Among All Patients Undergoing Transcatheter Aortic Valve Implantation in Germany: A Retrospective Observational Study. Int J Cardiol, 2017; 235: 17-21. : http://dx.doi.org/10.1016/j.ijcard.2017.02.138
  • Kasenda B, Ihorst G, Schroers R, Korfel A, Schmidt-Wolf I, Egerer G, von Baumgarten L, Roeth A, Bloehdorn J, Moehle R, Binder M, Keller U, Lamprecht M, Pfreundschuh M, Valk E, Fricker H, Schorb E, Fritsch K, Finke J, Illerhaus G: High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group. Leukemia, 2017; 31 (12): 2623-2629. : http://dx.doi.org/10.1038/leu.2017.170
  • Landgrebe M, Hajak G, Wolf S, Padberg F, Klupp P, Fallgatter AJ, Polak T, Hoppner J, Haker R, Cordes J, Klenzner T, Schonfeldt-Lecuona C, Kammer T, Graf E, Koller M, Kleinjung T, Lehner A, Schecklmann M, Poppl TB, Kreuzer P, Frank E, Langguth B: 1-Hz rTMS in the treatment of tinnitus: A sham-controlled, randomized multicenter trial. Brain Stimul, 2017; 10 (6): 1112-1120. : http://dx.doi.org/10.1016/j.brs.2017.08.001
  • Lorenz E, Jenkner C, Sauerbrei W, Becher H: Modeling Variables With a Spike at Zero: Examples and Practical Recommendations. Am J Epidemiol, 2017; 185 (8): 650-660. : http://dx.doi.org/10.1093/aje/kww122
  • Luebbert M, Ihorst G, Sander PN, Bogatyreva L, Becker H, Wijermans PW, Suciu S, Bissé E, Claus R: Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5-aza-2'-deoxycytidine (Decitabine). Brit J Haematol, 2017; 176 (4): 609-617. : http://dx.doi.org/10.1111/bjh.14463
  • Magnet FS, Callegari J, Dieninghoff D, Spielmanns M, Storre JH, Schmoor C, Windisch W: Impact of Pseudomonas aeruginosa Infection on Respiratory Muscle Function in Adult Cystic Fibrosis Patients. Respiration, 2017; 93 (1): 42-50. : http://dx.doi.org/10.1159/000452893
  • Magnet FS, Majorski DS, Callegari J, Schwarz SB, Schmoor C, Windisch W, Storre JH: Capillary PO2 does not adequately reflect arterial PO2 in hypoxemic COPD patients. Int J Chronic Obstr, 2017; 12: 2647-2653. : http://dx.doi.org/10.2147/COPD.S140843
  • Reinacher PC, Krueger MT, Coenen VA, Shah M, Roelz R, Jenkner C, Egger K: Determining the Orientation of Directional Deep Brain Stimulation Electrodes Using 3D Rotational Fluoroscopy. Am J Neuroradiol, 2017; 38 (6): 1111-1116. : http://dx.doi.org/10.3174/ajnr.A5153
  • Schubach F, Goos M, Fabry G, Vach W, Boeker M: Virtual patients in the acquisition of clinical reasoning skills: does presentation mode matter? A quasi-randomized controlled trial. Bmc Med Educ, 2017; 17 (1): 165-165. : http://dx.doi.org/10.1186/s12909-017-1004-2
  • Schwarz SB, Windisch W, Magnet FS, Schmoor C, Karagiannidis C, Callegari J, Huttmann SE, Storre JH: Continuous non-invasive PCO2 monitoring in weaning patients: Transcutaneous is advantageous over end-tidal PCO2. Respirology, 2017; 22 (8): 1579-1584. : http://dx.doi.org/10.1111/resp.13095
  • Speckmann C, Doerken S, Aiuti A, Albert MH, Al-Herz W, Allende LM, Scarselli A, Avcin T, Perez-Becker R, Cancrini C, Cant A, Di Cesare S, Finocchi A, Fischer A, Gaspar HB, Ghosh S, Gennery A, Gilmour K, Gonzalez-Granado LI, Martinez-Gallo M, Hambleton S, Hauck F, Hoenig M, Moshous D, Neven B, Niehues T, Notarangelo L, Picard C, Rieber N, Schulz A, Schwarz K, Seidel MG, Soler-Palacin P, Stepensky P, Strahm B, Vraetz T, Warnatz K, Winterhalter C, Worth A, Fuchs S, Uhlmann A, Ehl S: A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis. J Allergy Clin Immun, 2017; 139 (4): 1302-1310.e4. : http://dx.doi.org/10.1016/j.jaci.2016.07.040
  • Struessmann T, Fritsch K, Baumgarten A, Fietz T, Engelhardt M, Mertelsmann R, Ihorst G, Duyster J, Finke J, Marks R: Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of Brit J Haematol, 2017; 178 (6): 927-935. : http://dx.doi.org/10.1111/bjh.14802
  • Tinsel I, Siegel A, Schmoor C, Buchholz A, Niebling W: DECADE-pilot: decision aid, action planning, and follow-up support for patients to reduce the 10-year rist of cardiovascular diseases - a protocol of a randomized controlled pilot trial Pilot and Feasibility Studies, 2017; 3 (1) (online).
  • Verhaart IEC, Robertson A, Leary R, McMacken G, Koenig K, Kirschner J, Jones CC, Cook SF, Lochmüller H: A multi-source approach to determine SMA incidence and research ready population. J Neurol, 2017; 264 (7): 1465-1473. : http://dx.doi.org/10.1007/s00415-017-8549-1
  • Waldschmidt JM, Simon A, Wider D, Mueller SJ, Follo M, Ihorst G, Decker S, Lorenz J, Chatterjee M, Azab AK, Duyster J, Waesch R, Engelhardt M: CXCL12 and CXCR7 are relevant targets to reverse cell adhesion-mediated drug resistance in multiple myeloma. Brit J Haematol, 2017; 179 (1): 36-49. : http://dx.doi.org/10.1111/bjh.14807
  • Wuensch A, Goelz T, Ihorst G, Terris DD, Bertz H, Bengel J, Wirsching M, Fritzsche K: Effect of individualized communication skills training on physicians' discussion of clinical trials in oncology: results from a randomized controlled trial. Bmc Cancer, 2017; 17 (1): 264-264. : http://dx.doi.org/10.1186/s12885-017-3238-0
  • Zens M, Grotejohann B, Tassoni A, Duttenhoefer F, Sudkamp NP, Niemeyer P: Development of a Modular Research Platform to Create Medical Observational Studies for Mobile Devices. JMIR Res Protoc, 2017; 6 (5): e99-e99. : http://dx.doi.org/10.2196/resprot.7705
  • Allignol A, Beyersmann J, Schmoor C: Statistical issues in the analysis of adverse events in time-to-event data. Pharm Stat, 2016; 15 (4): 297-305. : http://dx.doi.org/10.1002/pst.1739
  • Baier P, Ihorst G, Wolff-Vorbeck G, Hull M, Hopt U, Deschler B: Independence and health related quality of life in 200 onco-geriatric surgical patients within 6 months of follow-up: Who is at risk to lose? Eur J Surg Oncol, 2016; 42 (12): 1890-1897. : http://dx.doi.org/10.1016/j.ejso.2016.07.013
  • Bickenbach J, Marx G, Schmoor C, Lemmen S, Marx N, Dreher M: Differences between prolonged weaning patients from medical and surgical intensive care units. Acta Anaesth Scand, 2016; 60 (9): 1270-1280. : http://dx.doi.org/10.1111/aas.12775
  • Cattaneo G, Schumacher M, Maurer C, Wolfertz J, Jost T, Buchert M, Keuler A, Boos L, Shah MJ, Foerster K, Niesen WD, Ihorst G, Urbach H, Meckel S: Endovascular Cooling Catheter for Selective Brain Hypothermia: An Animal Feasibility Study of Cooling Performance. Am J Neuroradiol, 2016; 37 (5): 885-891. : http://dx.doi.org/10.3174/ajnr.A4625
  • Chevalier N, Mueller M, Mougiakakos D, Ihorst G, Marks R, Schmitt-Graeff A, Veelken H: Analysis of dendritic cell subpopulations in follicular lymphoma with respect to the tumor immune microenvironment. Leuk Lymphoma, 2016; 57 (9): 2150-2160. : http://dx.doi.org/10.3109/10428194.2015.1135432
  • Coenen VA, Jenkner C, Honey CR, Madler B: Electrophysiologic Validation of Diffusion Tensor Imaging Tractography during Deep Brain Stimulation Surgery. Am J Neuroradiol, 2016; 37 (8): 1470-1478. : http://dx.doi.org/10.3174/ajnr.A4753
  • Diem R, Molnar F, Beisse F, Gross N, Drüschler K, Heinrich S P, Joachimsen L, Rauer S, Pielen A, Sühs K-W, Linker R A, Huchzermeyer C, Albrecht P, Hassenstein A, Aktas O, Guthoff T, Tonagel F, Kernstock C, Hartmann K, Kümpfel T, Hein K, van Oterendorp C, Grotejohann B, Ihorst G, Maurer J, Müller M, Volkmann M, Wildemann B, Platten M, Wick W, Heesen C, Schiefer U, Wolf S, Lagrèze W A: Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial—study protocol Bmj Open, 2016; 6 (online): e010956. : http://dx.doi.org/10.1136/bmjopen-2015-010956
  • Dreier G, Lohler J: Evidence and evidence gaps - an introduction. GMS Curr Top Otorhinolaryngol Head Neck Surg, 2016; 15: Doc11-Doc11. : http://dx.doi.org/10.3205/cto000138
  • Dreier G, Lohler J: [Evidence and Evidence Gaps - an Introduction]. Laryngo Rhino Otol, 2016; 95 Suppl 1: S6-S12. : http://dx.doi.org/10.1055/s-0041-108944
  • Engelhardt M, Dold SM, Ihorst G, Zober A, Moller M, Reinhardt H, Hieke S, Schumacher M, Wasch R: Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores. Haematologica, 2016; 101 (9): 1110-1119. : http://dx.doi.org/10.3324/haematol.2016.148189
  • Engelhardt M, Ihorst G, Caers J, Gunther A, Wasch R: Autotransplants in older multiple myeloma patients: hype or hope in the era of novel agents? Haematologica, 2016; 101 (11): 1276-1278. : http://dx.doi.org/10.3324/haematol.2016.154807
  • Finke J, Schmoor C, Bertz H, Marks R, Wasch R, Zeiser R, Hackanson B: Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation. Bone Marrow Transpl, 2016; 51 (6): 771-777. : http://dx.doi.org/10.1038/bmt.2015.338
  • Hauschke, D, Schmoor, C: Methodological aspects of the benefit assessment of medical interventions Biometrical J, 2016; 58 (1): 5-7. : http://dx.doi.org/10.1002/bimj.201500160
  • Hoeppner J, Lordick F, Brunner T, Glatz T, Bronsert P, Rothling N, Schmoor C, Lorenz D, Ell C, Hopt UT, Siewert JR: ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286). Bmc Cancer, 2016; 16 (online): 503. : http://dx.doi.org/10.1186/s12885-016-2564-y
  • Illerhaus G, Kasenda B, Ihorst G, Egerer G, Lamprecht M, Keller U, Wolf HH, Hirt C, Stilgenbauer S, Binder M, Hau P, Edinger M, Frickhofen N, Bentz M, Mohle R, Roth A, Pfreundschuh M, von Baumgarten L, Deckert M, Hader C, Fricker H, Valk E, Schorb E, Fritsch K, Finke J: High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial. Lancet Haematol, 2016; 3 (8): e388-e397. : http://dx.doi.org/10.1016/S2352-3026(16)30050-3
  • Jenkner C, Lorenz E, Becher H, Sauerbrei W: Modeling continuous covariates with a "spike" at zero: Bivariate approaches. Biometrical J, 2016; 58 (4): 783-796. : http://dx.doi.org/10.1002/bimj.201400112
  • Lohler J, Akcicek B, Muller F, Dreier G, Meerpohl JJ, Vach W, Werner JA: Evidence gaps in ENT surgery - a qualitative survey. GMS Curr Top Otorhinolaryngol Head Neck Surg, 2016; 15: Doc10-Doc10. : http://dx.doi.org/10.3205/cto000137
  • Lohler J, Akcicek B, Muller F, Dreier G, Meerpohl JJ, Vach W, Werner J: [Gaps of Evidence in ENT-Surgery - a Qualitative Survey]. Laryngo Rhino Otol, 2016; 95 Suppl 1: S13-S37. : http://dx.doi.org/10.1055/s-0041-108949
  • Lorenz J, Waldschmidt J, Wider D, Follo M, Ihorst G, Chatterjee M, May AM, Duyster J, Rosenwald A, Wasch R, Zirlik K, Engelhardt M: From CLL to Multiple Myeloma - Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration. Brit J Haematol, 2016; 174 (6): 985-989. : http://dx.doi.org/10.1111/bjh.13825
  • Lubbert M, Ihorst G, Sander PN, Bogatyreva L, Becker H, Wijermans PW, Suciu S, Bisse E, Claus R: Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5-aza-2'-deoxycytidine (Decitabine). Brit J Haematol, 2016 (online). : http://dx.doi.org/10.1111/bjh.14463
  • Maier S, Perlov E, Graf E, Dieter E, Sobanski E, Rump M, Warnke A, Ebert D, Berger M, Matthies S, Philipsen A, Tebartz van Elst L: Discrete Global but No Focal Gray Matter Volume Reductions in Unmedicated Adult Patients With Attention-Deficit/Hyperactivity Disorder. Biol Psychiat, 2016; 80 (12): 905-915. : http://dx.doi.org/10.1016/j.biopsych.2015.05.012
  • Maurer J, Grotejohann B, Jenkner C, Schneider C, Flury T, Tassoni A, Angele P, Fritz J, Albrecht D, Niemeyer P: A Registry for Evaluation of Efficiency and Safety of Surgical Treatment of Cartilage Defects: The German Cartilage Registry (KnorpelRegister DGOU). JMIR Res Protoc, 2016; 5 (2): e122-e122. : http://dx.doi.org/10.2196/resprot.5895
  • Oehlke O, Mix M, Graf E, Schimek-Jasch T, Nestle U, Gotz I, Schneider-Fuchs S, Weyerbrock A, Mader I, Baumert BG, Short SC, Meyer PT, Weber WA, Grosu AL: Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1). Bmc Cancer, 2016; 16 (1): 769-769. : http://dx.doi.org/10.1186/s12885-016-2806-z
  • Philipsen A, Tebartz van Elst L, Graf E: Quality of Life of Adult Patients With Attention-Deficit/Hyperactivity Disorder Taking Methylphenidate-Reply. Jama Psychiat, 2016; 73 (5): 534-535. : http://dx.doi.org/10.1001/jamapsychiatry.2016.0051
  • Plontke S K, Girndt M, Meisner C, Probst R, Oerlecke I, Richter M, Steighardt J, Dreier G, Weber A, Baumann I, Ploeßl S, Lohler J, Laszig R, Werner JA, Rahne T: Multizentrische Studie zur Hörsturztherapie - Planung und Konzeption. [ Multicenter trial for sudden hearing loss therapy – planning and concept]. Hno, 2016; 64 (4): 227-236. : http://link.springer.com/article/10.1007/s00106-016-0149-3 (download: http://download.springer.com/static/pdf/34/art%253A10.1007%252Fs00106-016-0149-3.pdf?originUrl=http%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00106-016-0149-3&token2=exp=1479378269~acl=%2Fstati)
  • Sajonz BE, Amtage F, Reinacher PC, Jenkner C, Piroth T, Katzler J, Urbach H, Coenen VA: Deep Brain Stimulation for Tremor Tractographic Versus Traditional (DISTINCT): Study Protocol of a Randomized Controlled Feasibility Trial. JMIR Res Protoc, 2016; 5 (4): e244-e244. : http://dx.doi.org/10.2196/resprot.6885
  • Schmoor C, Bender R, Beyersmann J, Kieser M, Schumacher M: Adverse event development in clinical oncology trials. Lancet Oncol, 2016; 17 (7): e263-e264. : http://dx.doi.org/10.1016/S1470-2045(16)30223-6
  • Schorb E, Finke J, Ferreri AJ, Ihorst G, Mikesch K, Kasenda B, Fritsch K, Fricker H, Burger E, Grishina O, Valk E, Zucca E, Illerhaus G: High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix). Bmc Cancer, 2016; 16: 282-282. : http://dx.doi.org/10.1186/s12885-016-2311-4
  • Solari L, Kronig M, Ihorst G, Drognitz K, Heinz J, Jilg CA, Schultze-Seemann W, Engelhardt M, Waller CF: High Rates of Thromboembolic Events in Patients with Germ Cell Cancer Undergoing Cisplatin-Based Polychemotherapy. Urol Int, 2016; 96 (4): 399-405. : http://dx.doi.org/10.1159/000445126
  • Spielmanns M, Gloeckl R, Schmoor C, Windisch W, Storre JH, Boensch M, Kenn K: Effects on pulmonary rehabilitation in patients with COPD or ILD: A retrospective analysis of clinical and functional predictors with particular emphasis on gender. Resp Med, 2016; 113: 8-14. : http://dx.doi.org/10.1016/j.rmed.2016.02.006
  • Theilacker C, Ludewig K, Serr A, Schimpf J, Held J, Bögelein M, Bahr, V, Rusch, S, Pohl, A, Kogelmann, K, Frieseke, S, Bogdanski, R, Brunkhorst, F M, Kern, W V, for the SPLEEN OFF Study Group: Overwhelming post-splenectomy infection: A prospective multicenter cohort study. Clin Infect Dis, 2016; 62 (7): 871-878. : http://dx.doi.org/10.1093/cid/civ1195
  • Urbain P, Ihorst G, Finke J, Bertz H: The impact of pre-transplant body weight on short- and long-term outcomes after allogeneic hematopoietic cell transplantation in adults using different weight classification tools. Bone Marrow Transpl, 2016; 51 (1): 144-147. : http://dx.doi.org/10.1038/bmt.2015.219
  • Vry J, Gramsch K, Rodger S, Thompson R, Steffensen BF, Rahbek J, Doerken S, Tassoni A, Beytia ML, Guergueltcheva V, Chamova T, Tournev I, Kostera-Pruszczyk A, Kaminska A, Lusakowska A, Mrazova L, Pavlovska L, Strenkova J, Vondracek P, Garami M, Karcagi V, Herczegfalvi A, Bushby K, Lochmuller H, Kirschner J: European Cross-Sectional Survey of Current Care Practices for Duchenne Muscular Dystrophy Reveals Regional and Age-Dependent Differences. J Neuromuscul Dis, 2016; 3 (4): 517-527. : http://dx.doi.org/10.3233/JND-160185
  • Belzer F, Kleinert L, Buchholz A, Mall V, Barth M: Pädiatrische Einschätzung von elterlichen Belastungen und Unterstützungsbedarf. Praev Gesundheitsf, 2015; 10: 314-319. : http://dx.doi.org/10.1007/s11553-015-0513-2
  • Callizo J, Feltgen N, Pantenburg S, Wolf A, Neubauer AS, Jurklies B, Wachter R, Schmoor C, Schumacher M, Junker B, Pielen A: Cardiovascular Risk Factors in Central Retinal Artery Occlusion: Results of a Prospective and Standardized Medical Examination. Ophthalmology, 2015; 122 (9): 1881-1888. : http://dx.doi.org/10.1016/j.ophtha.2015.05.044
  • Conrad A, Grotejohann B, Schmoor C, Cosic D, Dettenkofer M: Safety and tolerability of virucidal hand rubs: a randomized, double-blind, cross-over trial with healthy volunteers Antimicrobial Resistance and Infection Control, 2015; 4 (online): 37. : http://dx.doi.org/10.1186/s13756-015-0079-y
  • Dittrich S, Tuerk M, Haaker G, Greim V, Buchholz A, Burkhardt B, Fujak A, Trollmann R, Schmid A, Schroeder R: Cardiomyopathy in Duchenne Muscular Dystrophy: Current Value of Clinical, Electrophysiological and Imaging Findings in Children and Teenagers. Klin Padiatr, 2015; 227 (4): 225-231. : http://dx.doi.org/10.1055/s-0034-1398689
  • Dreher M, Ekkernkamp E, Schmoor C, Schoenheit-Kenn U, Winterkamp S, Kenn K: Pulmonary rehabilitation and noninvasive ventilation in patients with hypercapnic interstitial lung disease. Respiration, 2015; 89 (3): 208-213. : http://dx.doi.org/10.1159/000369862
  • Ekkernkamp E, Welte L, Schmoor C, Huttmann SE, Dreher M, Windisch W, Storre JH: Spot check analysis of gas exchange: invasive versus noninvasive methods. Respiration, 2015; 89 (4): 294-303. : http://dx.doi.org/10.1159/000371769
  • Endres D, Perlov E, Maier S, Feige B, Nickel K, Goll P, Bubl E, Lange T, Glauche V, Graf E, Ebert D, Sobanski E, Philipsen A, Tebartz van Elst L: Normal neurochemistry in the prefrontal and cerebellar brain of adults with attention-deficit hyperactivity disorder Front Behav Neurosci, 2015; 9 (online): 242. : http://dx.doi.org/10.3389/fnbeh.2015.00242
  • Engelhardt M, Ihorst G, Landgren O, Pantic M, Reinhardt H, Waldschmidt J, May AM, Schumacher M, Kleber M, Wäsch R: Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years. Haematologica, 2015; 100: 1340-1349. : http://dx.doi.org/10.3324/haematol.2015.127548
  • Fleck K, Jacob C, Philipsen A, Matthies S, Graf E, Hennighausen K, Haack-Dees B, Weyers P, Warnke A, Rosler M, Retz W, von Gontard A, Hanig S, Freitag C, Sobanski E, Schumacher-Stien M, Poustka L, Bliznak L, Becker K, Holtmann M, Colla M, Gentschow L, Kappel V, Jaite C, Jans T: Child impact on family functioning: a multivariate analysis in multiplex families with children and mothers both affected by attention-deficit/hyperactivity disorder (ADHD). Atten Defic Hyperact Disord, 2015; 7 (3): 211-223. : http://dx.doi.org/10.1007/s12402-014-0164-8
  • Grishina O, Schmoor C, Döhner K, Hackanson B, Lubrich B, May AM, Cieslik C, Müller MJ, Lübbert M: DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy. Bmc Cancer, 2015; 15 (online): 430. : http://dx.doi.org/10.1186/s12885-015-1432-5
  • Hieke S, Kleber M, Konig C, Engelhardt M, Schumacher M: Conditional Survival: A Useful Concept to Provide Information on How Prognosis Evolves over Time. Clin Cancer Res, 2015; 21 (7): 1530-1536. : http://dx.doi.org/10.1158/1078-0432.CCR-14-2154
  • Jans T, Jacob C, Warnke A, Zwanzger U, Groß-Lesch S, Matthies S, Borel P, Henninghausen K, Haack-Dees B, Rösler M, Retz W, von Gontard A, Hänig S, Sobanski E, Alm B, Poustka L, Hohmann S, Colla M, Gentschow L, Jaite C, Kappel V, Becker K, Holtmann M, Freitag C, Graf E, Ihorst G, Philipsen A: Does intensive multimodal treatment for maternal ADHD improve the efficacy of parent training for children with ADHD? A randomized controlled multicenter trial J Child Psychol Psyc, 2015; 56 (12): 1298-1313. : http://dx.doi.org/10.1111/jcpp.12443
  • Lang R, Baumann P, Schmoor C, Odermatt EK, Wente MN, Jauch KW: A-Part Gel, an adhesion prophylaxis for abdominal surgery: a randomized controlled phase I-II safety study [NCT00646412]. Ann Surg Innov Res, 2015; 9 (online): 5. : http://dx.doi.org/10.1186/s13022-015-0014-1
  • Leisser C, Kaufmann TA, Feltgen N, Schumacher M, Schmoor C, Meckel S: Distribution of internal carotid artery plaque locations among patients with central retinal artery occlusion in the Eagle study population. Graef Arch Clin Exp, 2015; 253 (8): 1227-1230. : http://dx.doi.org/10.1007/s00417-014-2804-2
  • Maier S, Perlov E, Graf E, Dieter E, Sobanski E, Rump M, Warnke A, Ebert D, Berger M, Matthies S, Philipsen A, Tebartz van Elst L: Discrete Global but No Focal Gray Matter Volume Reductions in Unmedicated Adult Patients with Attention-Deficit/Hyperactivity Disorder Biol Psychiat, 2015. : http://dx.doi.org/10.1016/j.biopsych.2015.05.012 (in Druck)
  • Naegele M, Leppla L, Kiote-Schmidt C, Ihorst G, Rebafka A, Koller A, May AM, Hasemann M, Duyster J, Wäsch R, Engelhardt M: Trained clinical nurse specialists proficiently obtain bone marrow aspirates and trephine biopsies in a nearly painless procedure-a prospective evaluation study. Ann Hematol, 2015; 94 (9): 1577-1584. : http://dx.doi.org/10.1007/s00277-015-2405-0
  • Niemeyer P, Schweigler K, Grotejohann B, Fritz J, Albrecht D: Mehr als 1000 Patienten im KnorpelRegister DGOU. Systematische Erfassung von Komplikationen und Behandlungsergebnissen nach knorpelregenerativen Eingriffen. Orthopädische Nachrichten - Kongressausgabe, 2015; 4: 2.
  • Niemeyer P, Schweigler K, Grotejohann B, Maurer J, Angele P, Aurich M, Becher C, Fay J, Feil R, Fickert S, Fritz J, Hoburg A, Kreuz P, Kolombe T, Laskowski J, Lützner J, Marlovits S, Müller PE, Niethammer T, Pietschmann M, Ruhnau K, Spahn G, Tischer T, Zinser W, Albrecht D: Das KnorpelRegister DGOU zur Erfassung von Behandlungsergebnissen nach Knorpeloperationen: Erfahrungen nach 6 Monaten und erste epidemiologische Daten. [The German Cartilage Registry (KnorpelRegister DGOU) for evaluation of surgical treatment for cartilage defects: experience after six months including first demographic data]. Z Orthop Unfallchir, 2015; 153 (1): 67-74. : http://dx.doi.org/10.1055/s-0034-1383222
  • Niemeyer P, Schweigler K, Grotejohann B, Maurer J, Angele P, Aurich M, Becher C, Fay J, Feil R, Fickert S, Fritz J, Hoburg A, Kreuz P, Kolombe T, Laskowski J, Lutzner J, Marlovits S, Muller PE, Niethammer T, Pietschmann M, Ruhnau K, Spahn G, Tischer T, Zinser W, Albrecht D: [The German Cartilage Registry (KnorpelRegister DGOU) for evaluation of surgical treatment for cartilage defects: experience after six months including first demographic data]. Z Orthop Unfallchir, 2015; 153 (1): 67-74. : http://dx.doi.org/10.1055/s-0034-1383222
  • Philipsen A, Jans T, Graf E, Matthies S, Borel P, Colla M, Gentschow L, Langner D, Jacob C, Gross-Lesch S, Sobanski E, Alm B, Schumacher-Stien M, Roesler M, Retz W, Retz-Junginger P, Kis B, Abdel-Hamid M, Heinrich V, Huss M, Kornmann C, Burger A, Perlov E, Ihorst G, Schlander M, Berger M, Tebartz van Elst L: Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. Jama Psychiat, 2015; 72 (12): 1199-1210. : http://dx.doi.org/10.1001/jamapsychiatry.2015.2146
  • Pielen A, Pantenburg S, Schmoor C, Schumacher M, Feltgen N, Junker B, Callizo J: Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment. Neuroradiology, 2015; 57 (10): 1055-1062. : http://dx.doi.org/10.1007/s00234-015-1588-3
  • Reinöhl J, Kaier K, Reinecke H, Schmoor C, Frankenstein L, Vach W, Cribier A, Beyersdorf F, Bode C, Zehender M: Effect of Availability of Transcatheter Aortic-Valve Replacement on Clinical Practice. New Engl J Med, 2015; 373 (25): 2438-2447. : http://dx.doi.org/10.1056/NEJMoa1500893
  • Sauerbrei W, Buchholz A, Boulesteix AL, Binder H: On stability issues in deriving multivariable regression models. Biometrical J, 2015; 57 (4): 531-555. : http://dx.doi.org/10.1002/bimj.201300222
  • Schweigler K, Grotejohann B, Maurer J, Albrecht D, Fritz J, Fickert S, Aurich M, Niemeyer P, Arbeitskreis Knorpel der Österreichischen Gesellschaft für Unfallchirurgie (Leiter: Marlovits S): Das KnorpelRegister DGOU. JATROS Unfallchirurgie & Sporttraumatologie, 2015; 10 (1): 28-30. (download: http://www.unfallchirurgen.at/download/jatros/Unfall_1501_Ansicht.pdf)
  • Taschner C, Chapot R, Costalat V, Courtheoux P, Barreau X, Berge J, Pierot L, Kadziolka K, Jean B, Blanc R, Biondi A, Brunel H, Gallas S, Berlis A, Herbreteau D, Berkefeld J, Groden C, Urbach H, El Shikh S, Graf E, Bonafe A: GREAT-a randomized aneurysm trial. Design of a randomized controlled multicenter study comparing HydroSoft/HydroFrame and bare platinum coils for endovascular aneurysm treatment. Neuroradiology, 2015; 57 (6): 599-604. : http://dx.doi.org/10.1007/s00234-015-1501-0
  • Weber J, Veith P, Jung B, Ihorst G, Moske-Eick O, Meckel S, Urbach H, Taschner CA: MR Angiography at 3 Tesla to Assess Proximal Internal Carotid Artery Stenoses: Contrast-Enhanced or 3D Time-of-Flight MR Angiography? Clin Neuroradiol, 2015; 25 (1): 41-48. : http://dx.doi.org/10.1007/s00062-013-0279-x
  • Zeiser R, Burchert A, Lengerke C, Verbeek M, Maas-Bauer K, Metzelder SK, Spoerl S, Ditschkowski M, Ecsedi M, Sockel K, Ayuk F, Ajib S, de Fontbrune FS, Na IK, Penter L, Holtick U, Wolf D, Schuler E, Meyer E, Apostolova P, Bertz H, Marks R, Lübbert M, Wäsch R, Scheid C, Stölzel F, Ordemann R, Bug G, Kobbe G, Negrin R, Brune M, Spyridonidis A, Schmitt-Gräff A, van der Velden W, Huls G, Mielke S, Grigoleit GU, Kuball J, Flynn R, Ihorst G, Du J, Blazar BR, Arnold R, Kroger N, Passweg J, Halter J, Socie G, Beelen D, Peschel C, Neubauer A, Finke J, Duyster J, von Bubnoff N: Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey. Leukemia, 2015; 29: 2062-2068. : http://dx.doi.org/10.1038/leu.2015.212
  • Blümle A, von Elm E, Antes G, Meerpohl JJ: Messung und Bewertung der Studienqualität und Berichtsqualität. [Measurement and assessment of study quality and reporting quality]. Z Evid Fortbild Qual Gesundhwes, 2014; 108 (8-9): 495-503. : http://dx.doi.org/10.1016/j.zefq.2014.09.022
  • Böhringer D, Ihorst G, Grotejohann B, Maurer J, Spierings E, Reinhard T: Functional antigen matching in corneal transplantation: matching for the HLA-A, -B and -DRB1 antigens (FANCY) - study protocol. Bmc Ophthalmol, 2014; 14 (1) (online): 156. : http://dx.doi.org/10.1186/1471-2415-14-156
  • Buchholz, A, Sauerbrei, W, Royston, P: A Measure for Assessing Functions of Time-Varying Effects in Survival Analysis Open Journal of Statistics, 2014; 4: 977-998. : http://dx.doi.org/10.4236/ojs.2014.411092
  • Bühlmann P, Gertheiss J, Hieke S, Kneib T, Ma S, Schumacher M, Tutz G, Wang C-Y, Wang Z, Ziegler A: Discussion of "The Evolution of Boosting Algorithms" and "Extending Statistical Boosting". Method Inform Med, 2014; 53: 436-445. : http://dx.doi.org/10.3414/13100122
  • Dreier G, Löhler J, Werner JA: Die medizinische Fachgesellschaft 2020 – wissenschaftliche, medizinische und ethische Verantwortung für mehr Evidenz in der Praxis. Zukunftsweisende Gründung eines Studienzentrums (DSZ-HNO) durch die Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie und den Deutschen Berufsverband der HNO-Ärzte. DZKF Deutsche Zeitschrift für Klinische Forschung, Innovation und Praxis, 2014; 18 (7): 16-18.
  • Ekkernkamp E, Kabitz HJ, Walker DJ, Schmoor C, Storre JH, Windisch W, Dreher M: Minute ventilation during spontaneous breathing, high-intensity noninvasive positive pressure ventilation and intelligent volume assured pressure support in hypercapnic COPD. Copd, 2014; 11 (1): 52-58. : http://dx.doi.org/10.3109/15412555.2013.829437
  • Farthmann J, Gabriel B, Niesel A, Fünfgeld C, Krauss A, Lenz F, Augenstein HJ, Graf E, Watermann D: Pelvic floor related quality of life after vaginal mesh implantation. Secondary endpoint of a prospective randomized trial. Pelviperineology, 2014; 33: 74-79. (download: http://www.pelviperineology.org/september-2014/pdf/pelviperineology-september-2014.pdf)
  • German National Cohort (GNC) Consortium (Schmoor C. u.a.): The German National Cohort: aims, study design and organization. Eur J Epidemiol, 2014; 29 (5): 371-382. : http://dx.doi.org/10.1007/s10654-014-9890-7
  • Grohmann J, Hohn R, Fleck T, Schmoor C, Stiller B: Transcatheter closure of atrial septal defects in children and adolescents: single-center experience with the GORE(R) septal occluder. Catheter Cardio Inte, 2014; 84 (6): E51-E57. : http://dx.doi.org/10.1002/ccd.25494
  • Hieke S, Binder H, Nieters A, Schumacher M: minPtest: a resampling based gene region-level testing procedure for genetic case-control studies. Computation Stat, 2014; 29: 51-63. : http://dx.doi.org/10.1007/s00180-012-0391-4
  • Niemeyer P, Grotejohann B, Schweigler K, Maurer J: Knorpelregister DGOU: Wichtiger Beitrag zur Versorgungsforschung. Orthopädie und Unfallchirurgie: Mitteilungen und Nachrichten, 2014; 3 (1): 20-22. : http://dx.doi.org/10.1055/s-0034-1368738 (download: http://www.knorpelregister-dgou.de/fileadmin/user_upload/Knorpelregister/Dokumente/Knorpelregister_OUMN_01_2014.pdf)
  • Niemeyer P, Schweigler K, Grotejohann B, Fritz J, Albrecht D: Ein Jahr KnorpelRegister DGOU. Erfahrungen und Ausblick. Orthopädische Nachrichten, 2014; 10: 44. (download: http://www.knorpelregister-dgou.de/fileadmin/user_upload/Knorpelregister/Dokumente/2014_1410_OrthoN_S44.pdf)
  • Philipsen A, Graf E, Jans T, Matthies S, Borel P, Colla M, Gentschow L, Langner D, Jacob C, Gross-Lesch S, Sobanski E, Alm B, Schumacher-Stien M, Roesler M, Retz W, Retz-Junginger P, Kis B, Abdel-Hamid M, Heinrich V, Huss M, Kornmann C, Burger A, van Elst LT, Berger M: A randomized controlled multicenter trial on the multimodal treatment of adult attention-deficit hyperactivity disorder: enrollment and characteristics of the study sample. Atten Defic Hyperact Disord, 2014; 6 (1): 35-47. : http://dx.doi.org/10.1007/s12402-013-0120-z
  • Sinnaeve PR, Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Lambert Y, Danays T, Soulat L, Halvorsen S, Ortiz FR, Vandenberghe K, Regelin A, Bluhmki E, Bogaerts K, Van de Werf F: ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up. Circulation, 2014; 130 (14): 1139-1145. : http://dx.doi.org/10.1161/CIRCULATIONAHA.114.009570
  • Storre JH, Huttmann SE, Ekkernkamp E, Walterspacher S, Schmoor C, Dreher M, Windisch W: Oxygen Supplementation in Noninvasive Home Mechanical Ventilation: The Crucial Roles of CO2 Exhalation Systems and Leakages. Resp Care, 2014; 59 (1): 113-120. : http://dx.doi.org/10.4187/respcare.02596
  • Storre JH, Matrosovich E, Ekkernkamp E, Walker DJ, Schmoor C, Dreher M, Windisch W: Home Mechanical Ventilation for COPD: High-Intensity Versus Target Volume Noninvasive Ventilation. Resp Care, 2014; 59 (9): 1389-1397. : http://dx.doi.org/10.4187/respcare.02941
  • Streckmann F, Kneis S, Leifert JA, Baumann FT, Kleber M, Ihorst G, Herich L, Grussinger V, Gollhofer A, Bertz H: Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy. Ann Oncol, 2014; 25 (2): 493-499. : http://dx.doi.org/10.1093/annonc/mdt568
  • Asbach S, Hartmann M, Wengenmayer T, Graf E, Bode C, Biermann J: Vector selection of a quadripolar left ventricular pacing lead affects acute hemodynamic response to cardiac resynchronization therapy: a randomized cross-over trial. Plos One, 2013; 8 (6): e67235-e67235. : http://dx.doi.org/10.1371/journal.pone.0067235
  • Boeynaems JM, Canivet C, Chan A, Clarke MJ, Cornu C, Daemen E, Demotes J, Nys KD, Hirst B, Hundt F, Kassai B, Kerpel-Fronius S, Kiessig L, Klech H, Kraehenbuhl JP, Lafolie P, Lucht M, Niese D, Pauli-Magnus C, Peters B, Schaltenbrand R, Stockis A, Stykova M, Verheus N, Klingmann I: A European approach to clinical investigator training. Front Pharmacol, 2013; 4: 112-112. : http://dx.doi.org/10.3389/fphar.2013.00112
  • Christiansen H, Hirsch O, Philipsen A, Oades RD, Matthies S, Hebebrand J, Ueckermann J, Abdel-Hamid M, Kraemer M, Wiltfang J, Graf E, Colla M, Sobanski E, Alm B, Rosler M, Jacob C, Jans T, Huss M, Schimmelmann BG, Kis B: German validation of the conners adult ADHD rating scale-self-report: confirmation of factor structure in a large sample of participants with ADHD. J Atten Disord, 2013; 17 (8): 690-698. : http://dx.doi.org/10.1177/1087054711435680
  • Christopoulos P, Schmoor C, Waterhouse M, Marks R, Wasch R, Bertz H, Finke J: Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML. Bone Marrow Transpl, 2013; 48 (7): 901-907. : http://dx.doi.org/10.1038/bmt.2012.267
  • Deschler B, Ihorst G, Platzbecker U, Germing U, Marz E, de Figuerido M, Fritzsche K, Haas P, Salih HR, Giagounidis A, Selleslag D, Labar B, de Witte T, Wijermans P, Lubbert M: Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Haematologica, 2013; 98 (2): 208-216. : http://dx.doi.org/10.3324/haematol.2012.067892
  • Duque-Afonso J, Ihorst G, Wasch R, Bertz H, Muller-Quernheim J, Finke J, Prasse A, Marks R: Identification of risk factors for bronchiolitis obliterans syndrome after reduced toxicity conditioning before hematopoietic cell transplantation. Bone Marrow Transpl, 2013; 48 (8): 1098-1103. : http://dx.doi.org/10.1038/bmt.2013.3
  • Farthmann J, Watermann D, Niesel A, Funfgeld C, Kraus A, Lenz F, Augenstein HJ, Graf E, Gabriel B: Lower exposure rates of partially absorbable mesh compared to nonabsorbable mesh for cystocele treatment: 3-year follow-up of a prospective randomized trial. Int Urogynecol J, 2013; 24 (5): 749-758. : http://dx.doi.org/10.1007/s00192-012-1929-2
  • Gross BN, Ihorst G, Jung M, Wasch R, Engelhardt M: Posaconazole therapeutic drug monitoring in the real-life setting: a single-center experience and review of the literature. Pharmacotherapy, 2013; 33 (10): 1117-1125. : http://dx.doi.org/10.1002/phar.1328
  • Heilmann C, Schmoor C, Siepe M, Schlensak C, Hoh A, Fraedrich G, Beyersdorf F: Controlled reperfusion versus conventional treatment of the acutely ischemic limb: results of a randomized, open-label, multicenter trial. Circ-cardiovasc Inte, 2013; 6 (4): 417-427. : http://dx.doi.org/10.1161/CIRCINTERVENTIONS.112.000371
  • Jans T, Graf E, Jacob C, Zwanzger U, Gross-Lesch S, Matthies S, Perlov E, Hennighausen K, Jung M, Rosler M, Schulte-Altedorneburg M, von Gontard A, Hanig S, Sobanski E, Alm B, Poustka L, Bliznak L, Colla M, Gentschow L, Burghardt R, Salbach-Andrae H, Becker K, Holtmann M, Freitag C, Warnke A, Philipsen A: A randomized controlled multicentre trial on the treatment for ADHD in mothers and children: enrolment and basic characteristics of the study sample. Atten Defic Hyperact Disord, 2013; 5 (1): 29-40. : http://dx.doi.org/10.1007/s12402-012-0092-4
  • Kleber M, Ihorst G, Gross B, Koch B, Reinhardt H, Wasch R, Engelhardt M: Validation of the Freiburg Comorbidity Index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcome. Clin Lymphoma Myeloma Leuk, 2013; 13 (5): 541-551. : http://dx.doi.org/10.1016/j.clml.2013.03.013
  • Kollum M, Heitzer T, Schmoor C, Brunner M, Witzenbichler B, Wiemer M, Hoffmann R, Gutleben KJ, Schultheiss HP, Horstkotte D, Brachmann J, Meinertz T, Bode Ch, Zehender M: Intra-individual head-to-head comparison of Sirolimus(R)- and Paclitaxel(R)-eluting stents for coronary revascularization. A randomized, multi-center trial. Int J Cardiol, 2013; 167 (4): 1552-1559. : http://dx.doi.org/10.1016/j.ijcard.2012.04.095
  • Konig C, Kleber M, Ihorst G, Gropp A, Reinhardt H, Koch B, Wasch R, Engelhardt M: Prevalence of iron overload vs iron deficiency in multiple myeloma: resembling or different from MDS--and stem cell transplant (SCT)--patients? Clin Lymphoma Myeloma Leuk, 2013; 13 (6): 671-680.e3. : http://dx.doi.org/10.1016/j.clml.2013.06.001
  • Rodger S, Lochmuller H, Tassoni A, Gramsch K, Konig K, Bushby K, Straub V, Korinthenberg R, Kirschner J: The TREAT-NMD care and trial site registry: an online registry to facilitate clinical research for neuromuscular diseases. Orphanet J Rare Dis, 2013; 8 (1) (online): 171-171. : http://dx.doi.org/10.1186/1750-1172-8-171
  • Schindler C, Feuchtinger J, Eichenlaub J, Gerhardt K, Schmoor C, Zinn J, Fritzsche K: Gemeinsam durch schwere Zeiten: Die Psychosomatik Liaison Nurse Psych Pflege, 2013; 19 (1): 41-44. : http://dx.doi.org/10.1055/s-0032-1333402
  • Schmoor C, Schumacher M, Finke J, Beyersmann J: Competing Risks and Multistate Models. Clin Cancer Res, 2013; 19 (1): 12-21. : http://dx.doi.org/10.1158/1078-0432.CCR-12-1619
  • Schumacher M, Schmoor C, Plog A, Schwarzwald R, Taschner Ch, Echternach M, Richter B, Spahn C: Motor functions in trumpet playing-a real-time MRI analysis. Neuroradiology, 2013; 55 (9): 1171-1181. : http://dx.doi.org/10.1007/s00234-013-1218-x
  • Tinsel I, Buchholz A, Vach W, Siegel A, Durk T, Buchholz A, Niebling W, Fischer KG: Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial. Bmc Fam Pract, 2013; 14 (online): 135-135. : http://dx.doi.org/10.1186/1471-2296-14-135
  • Udi J, Schuler J, Wider D, Ihorst G, Catusse J, Waldschmidt J, Schnerch D, Follo M, Wasch R, Engelhardt M: Potent in vitro and in vivo activity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerization. Brit J Haematol, 2013; 161 (1): 104-116. : http://dx.doi.org/10.1111/bjh.12226
  • Urbain P, Birlinger J, Ihorst G, Biesalski HK, Finke J, Bertz H: Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation. Ann Hematol, 2013; 92 (1): 111-119. : http://dx.doi.org/10.1007/s00277-012-1573-4
  • Winzer KJ, Buchholz A, Guski H, Frohberg HD, Diekmann F, Possinger K, Sauerbrei W: Treatment of primary breast cancer at the surgical unit of the charite 1984-1998. Onkologie, 2013; 36 (12): 727-736. : http://dx.doi.org/10.1159/000356805
  • Bertz H, Spyridonidis A, Ihorst G, Engelhardt M, Grullich C, Wasch R, Marks R, Finke J: Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia. Biol Blood Marrow Tr, 2012; 18 (6): 894-902. : http://dx.doi.org/10.1016/j.bbmt.2011.11.017
  • Christiansen H, Kis B, Hirsch O, Matthies S, Hebebrand J, Uekermann J, Abdel-Hamid M, Kraemer M, Wiltfang J, Graf E, Colla M, Sobanski E, Alm B, Rosler M, Jacob C, Jans T, Huss M, Schimmelmann BG, Philipsen A: German validation of the Conners Adult ADHD Rating Scales (CAARS) II: reliability, validity, diagnostic sensitivity and specificity. Eur Psychiat, 2012; 27 (5): 321-328. : http://dx.doi.org/10.1016/j.eurpsy.2010.12.010
  • Christopoulos P, Bertz H, Ihorst G, Marks R, Wasch R, Finke J: Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity. Biol Blood Marrow Tr, 2012; 18 (9): 1430-1437. : http://dx.doi.org/10.1016/j.bbmt.2012.02.016
  • Decker S, Zirlik K, Djebatchie L, Hartmann D, Ihorst G, Schmitt-Graeff A, Herchenbach D, Jumaa H, Warmuth M, Veelken H, Dierks C: Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL. Blood, 2012; 119 (4): 997-1007. : http://dx.doi.org/10.1182/blood-2011-06-359075
  • Finke J, Schmoor C, Bethge WA, Ottinger HD, Stelljes M, Zander AR, Volin L, Heim DA, Schwerdtfeger R, Kolbe K, Mayer J, Maertens JA, Linkesch W, Holler E, Koza V, Bornhauser M, Einsele H, Bertz H, Grishina O, Socie G: Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial. Biol Blood Marrow Tr, 2012; 18 (11): 1716-1726. : http://dx.doi.org/10.1016/j.bbmt.2012.06.001
  • Gluud C, Kubiac C, Whitfield K, Byrne J, Huemer KH, Thirstrup S, Libersa C, Barraud B, Grahlert X, Dreier G, Geismann S, Kuchinke W, Temesvari Z, Blasko G, Kardos G, O'Brien T, Cooney M, Gaynor S, Schieppati A, de Andres F, Sanz N, Kreis G, Asker-Hagelberg C, Johansson H, Bourne S, Asghar A, Husson JM, Demotes-Mainard J: Typical investigational medicinal products follow relatively uniform regulations in 10 European Clinical Research Infrastructures Network (ECRIN) countries. Trials, 2012; 13 (1): 27-27. : http://dx.doi.org/10.1186/1745-6215-13-27
  • Haas PS, Ihorst G, Schnitzler S, Wasch R, Marks R, Bertz H, Mertelsmann R, Finke J, Deschler B: NT-pro-BNP: not the prognostic all-rounder in elderly patients undergoing allogeneic stem cell transplantation. Ann Hematol, 2012; 91 (12): 1929-1935. : http://dx.doi.org/10.1007/s00277-012-1529-8
  • Harder J, Ihorst G, Heinemann V, Hofheinz R, Moehler M, Buechler P, Kloeppel G, Rocken C, Bitzer M, Boeck S, Endlicher E, Reinacher-Schick A, Schmoor C, Geissler M: Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer. Brit J Cancer, 2012; 106 (6): 1033-1038. : http://dx.doi.org/10.1038/bjc.2012.18
  • Hasskarl J, Zerweck A, Wasch R, Ihorst G, Bertz H, Finke J: Induction of graft versus malignancy effect after unrelated allogeneic PBSCT using donor lymphocyte infusions derived from frozen aliquots of the original graft. Bone Marrow Transpl, 2012; 47 (2): 277-282. : http://dx.doi.org/10.1038/bmt.2011.45
  • Hoeltzenbein M, Elefant E, Vial T, Finkel-Pekarsky V, Stephens S, Clementi M, Allignol A, Weber-Schoendorfer C, Schaefer C: Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am J Med Genet A, 2012; 158A (3): 588-596. : http://dx.doi.org/10.1002/ajmg.a.35223
  • Hoeltzenbein M, Weber-Schoendorfer C, Borisch C, Allignol A, Meister R, Schaefer C: Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurine. Reprod Toxicol, 2012; 34 (3): 364-369. : http://dx.doi.org/10.1016/j.reprotox.2012.05.001
  • Jans T, Graf E, Jacob C, Zwanzger U, Gross-Lesch S, Matthies S, Perlov E, Hennighausen K, Jung M, Rosler M, Schulte-Altedorneburg M, von Gontard A, Hanig S, Sobanski E, Alm B, Poustka L, Bliznak L, Colla M, Gentschow L, Burghardt R, Salbach-Andrae H, Becker K, Holtmann M, Freitag C, Warnke A, Philipsen A: A randomized controlled multicentre trial on the treatment for ADHD in mothers and children: enrolment and basic characteristics of the study sample. Atten Defic Hyperact Disord, 2012. : http://dx.doi.org/10.1007/s12402-012-0092-4
  • Kleber M, Ihorst G, Udi J, Koch B, Wasch R, Engelhardt M: Prognostic risk factor evaluation in patients with relapsed or refractory multiple myeloma receiving lenalidomide treatment: analysis of renal function by eGFR and of additional comorbidities by comorbidity appraisal. Clin Lymphoma Myeloma Leuk, 2012; 12 (1): 38-48. : http://dx.doi.org/10.1016/j.clml.2011.09.216
  • Lubbert M, Ruter BH, Claus R, Schmoor C, Schmid M, Germing U, Kuendgen A, Rethwisch V, Ganser A, Platzbecker U, Galm O, Brugger W, Heil G, Hackanson B, Deschler B, Dohner K, Hagemeijer A, Wijermans PW, Dohner H: A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy. Haematologica, 2012; 97 (3): 393-401. : http://dx.doi.org/10.3324/haematol.2011.048231
  • Oppermann M, Fritzsche J, Weber-Schoendorfer C, Keller-Stanislawski B, Allignol A, Meister R, Schaefer C: A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine, 2012; 30 (30): 4445-4452. : http://dx.doi.org/10.1016/j.vaccine.2012.04.081
  • Reinhard M, Schork J, Allignol A, Weiller C, Kaube H: Cerebellar and cerebral autoregulation in migraine. Stroke, 2012; 43 (4): 987-993. : http://dx.doi.org/10.1161/STROKEAHA.111.644674
  • Riesterer, R: Marketing certification of bioimplants: feasible or not? Meditec, 2012; 3: 34-37. (download: http://pr-hoch-drei.de/pdf/MEDITEC_Bioimplantate_3-2012.pdf)
  • Tinsel I, Buchholz A, Vach W, Siegel A, Durk T, Loh A, Buchholz A, Niebling W, Fischer KG: Implementation of shared decision making by physician training to optimise hypertension treatment. Study protocol of a cluster-RCT. Bmc Cardiovasc Disor, 2012; 12: 73-73. : http://dx.doi.org/10.1186/1471-2261-12-73
  • Urbain P, Ihorst G, Biesalski HK, Bertz H: Course of serum 25-hydroxyvitamin D(3) status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation. Ann Hematol, 2012; 91 (5): 759-766. : http://dx.doi.org/10.1007/s00277-011-1365-2
  • Wolkewitz M, Allignol A, Harbarth S, de Angelis G, Schumacher M, Beyersmann J: Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias. J Clin Epidemiol, 2012; 65 (11): 1171-1180. : http://dx.doi.org/10.1016/j.jclinepi.2012.04.008
  • Arndt S, Aschendorff A, Laszig R, Beck R, Schild C, Kroeger S, Ihorst G, Wesarg T: Comparison of pseudobinaural hearing to real binaural hearing rehabilitation after cochlear implantation in patients with unilateral deafness and tinnitus. Otol Neurotol, 2011; 32 (1): 39-47. : http://dx.doi.org/10.1097/MAO.0b013e3181fcf271
  • Arndt S, Laszig R, Aschendorff A, Beck R, Schild C, Hassepass F, Ihorst G, Kroeger S, Kirchem P, Wesarg T: [Unilateral deafness and cochlear implantation: audiological diagnostic evaluation and outcomes]. Hno, 2011; 59 (5): 437-446. : http://dx.doi.org/10.1007/s00106-011-2318-8
  • Buchholz A, Sauerbrei W: Comparison of procedures to assess non-linear and time-varying effects in multivariable models for survival data. Biometrical J, 2011; 53 (2): 308-331. : http://dx.doi.org/10.1002/bimj.201000159
  • Dreher M, Ekkernkamp E, Walterspacher S, Walker D, Schmoor C, Storre JH, Windisch W: Noninvasive ventilation in COPD: impact of inspiratory pressure levels on sleep quality. Chest, 2011; 140 (4): 939-945. : http://dx.doi.org/10.1378/chest.11-0253
  • Engelhardt M, Ihorst G, Udi J, Kleber M, Rawluk J, Wasch R: Does colorectal cancer in ulcerative colitis patients constitute a risk for chemotherapy refractoriness?:a systemic approach by detailed analysis via the electronic tumor base documentation system. Onkologie, 2011; 34 (12): 688-694. : http://dx.doi.org/10.1159/000334543
  • Forster J, Ihorst G, Spindler T, Jaeschke R, Szczepanski R: Criteria for the differential indication of asthma education versus asthma instruction for families of preschoolers: results from the randomized DIAT2 study (Differential Indication of Asthma Trainings in Toddlers). Klin Padiatr, 2011; 223 (4): 227-230. : http://dx.doi.org/10.1055/s-0031-1279761
  • Fritsch K, Kasenda B, Hader C, Nikkhah G, Prinz M, Haug V, Haug S, Ihorst G, Finke J, Illerhaus G: Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly. Ann Oncol, 2011; 22 (9): 2080-2085. : http://dx.doi.org/10.1093/annonc/mdq712
  • Geismann S, Kirschner J, Tassoni A: TREAT-NMD Regulatory Affairs Database – eine webbasierte Datenbank zu Regularien in klinischen Studien DZKF, 2011; 2011 (3/4): 74-77.
  • Goelz T, Wuensch A, Stubenrauch S, Ihorst G, de Figueiredo M, Bertz H, Wirsching M, Fritzsche K: Specific training program improves oncologists' palliative care communication skills in a randomized controlled trial. J Clin Oncol, 2011; 29 (25): 3402-3407. : http://dx.doi.org/10.1200/JCO.2010.31.6372
  • Hasskarl J, Ihorst G, De Pasquale D, Schrottner P, Zerweck A, Wasch R, Engelhardt M: Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma. Leuk Lymphoma, 2011; 52 (2): 247-259. : http://dx.doi.org/10.3109/10428194.2010.529207
  • Jena S, Antes G, Dreier G, Schumacher M: Transparenz bei Arzneimittel- und anderen klinischen Studien – kein gelöstes Problem! Deutsche Zeitschrift für Klinische Forschung, 2011; 1: 58-62.
  • Kleber M, Ihorst G, Terhorst M, Koch B, Deschler B, Wasch R, Engelhardt M: Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity score. Blood Cancer J, 2011; 1 (9): e35-e35. : http://dx.doi.org/10.1038/bcj.2011.34
  • Kleber M, Ihorst G, Terhorst M, Koch B, Deschler B, Wasch R, Engelhardt M: Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity score. Blood Cancer J, 2011; 1 (9): e35-e35. : http://dx.doi.org/10.1038/bcj.2011.34
  • Navarrete MA, Heining-Mikesch K, Schuler F, Bertinetti-Lapatki C, Ihorst G, Keppler-Hafkemeyer A, Dolken G, Veelken H: Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma. Blood, 2011; 117 (5): 1483-1491. : http://dx.doi.org/10.1182/blood-2010-06-292342
  • Schmoor C, Gall C, Stampf S, Graf E: Correction of confounding bias in non-randomized studies by appropriate weighting. Biometrical J, 2011; 53 (2): 369-387. : http://dx.doi.org/10.1002/bimj.201000154
  • Schoop R, Beyersmann J, Schumacher M, Binder H: Quantifying the predictive accuracy of time-to-event models in the presence of competing risks. Biometrical J, 2011; 53 (1): 88-112. : http://dx.doi.org/10.1002/bimj.201000073
  • Schoop R, Schumacher M, Graf E: Measures of prediction error for survival data with longitudinal covariates. Biometrical J, 2011; 53 (2): 275-293. : http://dx.doi.org/10.1002/bimj.201000145
  • Socie G, Schmoor C, Bethge WA, Ottinger HD, Stelljes M, Zander AR, Volin L, Ruutu T, Heim DA, Schwerdtfeger R, Kolbe K, Mayer J, Maertens JA, Linkesch W, Holler E, Koza V, Bornhauser M, Einsele H, Kolb HJ, Bertz H, Egger M, Grishina O, Finke J: Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood, 2011; 117 (23): 6375-6382. : http://dx.doi.org/10.1182/blood-2011-01-329821
  • Udi J, Wider D, Kleber M, Ihorst G, Muller A, Wasch R, Engelhardt M: Early and mature endothelial progenitors and VEGFR2+-cells in multiple myeloma: association with disease characteristics and variation in different cell compartments. Leukemia Res, 2011; 35 (9): 1265-1268. : http://dx.doi.org/10.1016/j.leukres.2011.05.021
  • Urbain P, Singler F, Ihorst G, Biesalski HK, Bertz H: Bioavailability of vitamin D from UV-B-irradiated button mushrooms in healthy adults deficient in serum 25-hydroxyvitamin D: a randomized controlled trial. Eur J Clin Nutr, 2011; 65 (8): 965-971. : http://dx.doi.org/10.1038/ejcn.2011.53
  • Denz U, Bertz H, Ihorst G, Wäsch R, Finke J: Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantation Bone Marrow Transpl, 2010; 45: 1309-1315. : http://dx.doi.org/10.1038/bmt.2009.341 (download: http://www.nature.com/bmt/journal/v45/n8/pdf/bmt2009341a.pdf)
  • Deschler B, Binek K, Ihorst G, Marks R, Wäsch R, Bertz H, Finke J: Prognostic Factor and Quality of Life Analysis in 160 Patients Aged ≥60 Years with Hematologic Neoplasias Treated with Allogeneic Hematopoietic Cell Transplantation Biol Blood Marrow Tr, 2010; 16 (7): 967-975. : http://dx.doi.org/10.1016/j.bbmt.2010.02.004 (download: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B758K-4YB792V-1-5&_cdi=12929&_user=1634520&_pii=S1083879110000595&_origin=search&_coverDate=07%2F31%2F2010&_sk=999839992&view=c&wchp=dGLbVlb-zSk)
  • Dettenkofer M, Wilson C, Gratwohl A, Schmoor C, Bertz H, Frei R, Heim D, Luft D, Schulz S, Widmer AF: Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a double-blind, randomized, controlled trial. Clin Microbiol Infec, 2010; 16 (6): 600-606. : http://dx.doi.org/10.1111/j.1469-0691.2009.02917.x
  • Dreher M, Storre JH, Schmoor C, Windisch W: High-intensity versus low-intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trial. Thorax, 2010; 65 (4): 303-308. : http://dx.doi.org/10.1136/thx.2009.124263
  • Eiermann W, Graf E, Ataseven B, Conrad B, Hilfrich J, Massinger-Biebl H, Vescia S, Loibl S, von Minckwitz G, Schumacher M, Kaufmann M: Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial (GABG-IV E-93) - the German Adjuvant Breast Cancer Group. Eur J Cancer, 2010; 46 (1): 84-94. : http://dx.doi.org/10.1016/j.ejca.2009.10.001
  • Hoek van der L, Ihorst G, Sure K, Vabret A, Dijkman R, de Vries M, Forster J, Berkhout B, Uberla K: Burden of disease due to human coronavirus NL63 infections and periodicity of infection. J Clin Virol, 2010; 48 (2): 104-108. : http://dx.doi.org/10.1016/j.jcv.2010.02.023
  • Hofmann S, Kopp G, Gall C, Bruckner-Tuderman L, Bertz H: Basement membrane antibodies in sera of haematopoietic cell recipients are associated with graft-versus-host disease. J Eur Acad Dermatol, 2010; 24 (5): 587-594. : http://dx.doi.org/10.1111/j.1468-3083.2009.03480.x
  • Kirschner J, Schessl J, Schara U, Reitter B, Stettner G M, Hobbiebrunken E, Wilichowski E, Bernert G, Weiss S, Stehling F, Wiegand G, Müller-Felber W, Thiele S, Grieben U, von der Hagen M, Lütschg J, Schmoor C, Ihorst G, Korinthenberg R: Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial Lancet Neurol, 2010; 9 (11): 1053-1059. : http://dx.doi.org/10.1016/S1474-4422(10)70196-4 (download: http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2810%2970196-4/fulltext#)
  • Lang R, Baumann P, Jauch KW, Schmoor C, Weis C, Odermatt E, Knaebel HP: A prospective, randomised, controlled, double-blind phase I-II clinical trial on the safety of A-Part® Gel as adhesion prophylaxis after major abdominal surgery versus non-treated group BMC Surgery, 2010; 10 (20): 3-9. : http://10.1186/1471-2482-10-20
  • Luft D, Schmoor C, Wilson C, Widmer A F, Bertz H, Frei R, Heim D, Dettenkofer M: Central venous catheter-associated bloodstream infection and colonisation of insertion site and catheter tip. What are the rates and risk factors in haematology patients? Ann Hematol, 2010; 89 (12): 1265-1275. : http://10.1007/s00277-010-1005-2 (download: http://springer.lib.tsinghua.edu.cn/content/v3302144015016t0/fulltext.pdf)
  • Ngo BT, Felthaus J, Hein M, Follo M, Wider D, Ihorst G, Engelhardt M, Wäsch R: Monitoring bortezomib therapy in multiple myeloma: screening of cyclin D1, D2, and D3 via reliable real-time polymerase chain reaction and association with clinico-pathological features and outcome Leukemia Lymphoma, 2010; 51 (9): 1632-1642. : http://dx.doi.org/10.3109/10428194.2010.496014
  • Philipsen A, Graf E, Tebartz van Elst L, Jans T, Warnke A, Hesslinger B, Ebert D, Gerlach M, Matthies S, Colla M, Jacob C, Sobanski E, Alm B, Rösler M, Ihorst G, Gross-Lesch S, Gentschow L, Kis B, Huss M, Lieb M, Schlander M, Berger M: Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial Attention Deficit And Hyperactivity Disorders, 2010; 2 (4): 203-212. : http://dx.doi.org/10.1007/s12402-010-0046-7
  • Reithmeier T, Graf E, Piroth T, Trippel M, Pinsker MO, Nikkhah G: BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors. Bmc Cancer, 2010; 10 (online): 30. : http://dx.doi.org/10.1186/1471-2407-10-30
  • Schumacher M, Schmidt D, Jurklies B, Gall C, Wanke I, Schmoor C, Maier-Lenz H, Solymosi L, Brueckmann H, Neubauer AS, Wolf A, Feltgen N: Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology, 2010; 117 (7): 1367-1375. : http://dx.doi.org/10.1016/j.ophtha.2010.03.061
  • Stampf S, Graf E, Schmoor C, Schumacher M: Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification Stat Med, 2010; 29 (7-8): 760-769. : http://10.1002/sim.3811 (download: http://onlinelibrary.wiley.com/doi/10.1002/sim.3811/pdf)
  • Szczepanski R, Jaeschke R, Spindler T, Ihorst G, Forster J, ASEV study group: Preschoolers' and parents' asthma education trial (P2AET)—a randomized controlled study Eur J Pediatr, 2010; 169 (9): 1051-1060. : http://10.1007/s00431-010-1173-z (download: http://www.springerlink.com/content/g4p118j2w367v685/fulltext.pdf)
  • Whitfield K, Huemer K H, Winter D, Thirstrup S, Libersa C, Barraud B, Kubiak C, Stankovski L, Grählert X, Dreier G, Geismann S, Kuchinke W, Strenge-Hesse A, Temesvari Z, Blasko G, Kardos G, O'Brien T, Cooney M, Gaynor S, Schieppati A, Serrano M, de Andres F, Sanz N, Hernández R, Kreis G, Asker-Hagelberg C, Johansson H, Asghar A, Husson J M, Demotes J, Gluud C: Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries Trials, 2010; 11 (104): 1-8. : http://doi:10.1186/1745-6215-11-104 (download: http://www.trialsjournal.com/content/pdf/1745-6215-11-104.pdf)
  • Wolf A, Schumacher M, Neubauer A S, Schmoor C, Gall C, Jurklies B, Wanke I, Solymosi L, Brückmann H, Schmidt D, Feltgen N: Vergleich der superselektiven intraarteriellen Fibrinolyse mit konservativer Therapie Einsatz bei Patienten mit akutem nichtarteriitischem Zentralarterienverschluss Ophthalmologe, 2010; 107 (9): 799-805. : http://10.1007/s00347-010-2247-z (download: http://springer.lib.tsinghua.edu.cn/content/2k034752g82678q1/fulltext.pdf)
  • Antes G, Dreier G, Hasselblatt H, Blumle A, Schumacher M: Clinical trials registers. Introduction to the topic and backgrounds Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2009; 52 (4): 459-462. : http://dx.doi.org/10.1007/s00103-009-0832-6
  • Dreier G, Hasselblatt H, Antes G, Schumacher M: The German Clinical Trials Register: reasons, general and technical aspects, international integration Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2009; 52 (4): 463-468. : http://dx.doi.org/10.1007/s00103-009-0833-5
  • Finke J, Bethge W A, Schmoor C, Ottinger H D, Stelljes M, Zander A R, Volin L, Ruutu T, Heim D A, Schwerdtfeger R, Kolbe K, Mayer J, Maertens J A, Linkesch W, Holler E, Koza V, Bornhäuser M, Einsele H, Kolb H-J, Bertz H, Egger M, Grishina O, Socié G: Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial lancet oncol, 2009; 10 (9): 855-864.
  • Illerhaus G, Marks R, Mller F, Ihorst G, Feuerhake F, Deckert M, Ostertag C, Finke J: High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study Ann Oncol, 2009; 20 (2): 319-325(7).
  • Jans T, Philipsen A, Graf E, Ihorst G, Gerlach M, Warnke A: Does the treatment of maternal attention deficit and hyperactivity disorder (ADHD) enhance the efficacy of a behavioural parent training for the treatment of their children’s ADHD? Study protocol of a randomized controlled multicentre trail ADHD Attention Deficit and Hyperactivity Disorders, 2009; 1 (1): 33-45. : http://dx.doi.org/10.1007/s12402-009-0004-4
  • Kleber M, Ihorst G, Deschler B, Jakob Ch, Liebisch P, Koch B, Sezer O, Engelhardt M: Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients. Eur J Haematol, 2009; 83 (6): 519-527.
  • Kubiak C, de Andres-Trelles F, Kuchinke W, Huemer KH, Thirstrup S, Whitfield K, Libersa C, Barraud B, Grahlert X, Dreier G *, Grychtol R *, Temesvari Z, Blasko G, Kardos G, O'Brien T, Cooney M, Gaynor S, Schieppati A, Sanz N, Hernandez R, Asker-Hagelberg C, Johansson H, Bourne S, Byrne J, Asghar A, Husson JM, Gluud C, Demotes-Mainard J: Common definition for categories of clinical research: a prerequisite for a survey on regulatory requirements by the European Clinical Research Infrastructures Network (ECRIN). Trials, 2009; 10 (online): 95. : http://dx.doi.org/10.1186/1745-6215-10-95
  • Vesper J, Graf E, WilleC, Tilgner, Trippel JM, Nikkhah G, Ostertag CB: Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors. Bmc Neurol, 2009; 9 (online): 33. : http://dx.doi.org/10.1186/1471-2377-9-33
  • Wink K, Otte A: Pharmakovigilanz- Die geschichtliche Entwicklung der Arzneimittelsicherheit und Überwachung ÄBW, 2009; 03: 105-108.
  • Haas P, Denz U, Ihorst G, Engelhardt M: Thalidomide in consecutive multiple myeloma patients: single-center analysis on practical aspects, efficacy, side effects and prognostic factors with lower thalidomide doses Eur J Haematol, 2008; 80 (4): 303-309.
  • Maier-Lenz H: Clinical Benefit Response (CBR) als Endpunkt für klinische Studien mit AMT bei soliden Tumoren Journal Onkologie, 2008; 05 (online): 1-4.
  • Marks R, Potthoff K, Hahn J, Ihorst G, Bertz H, Spyridonidis A, Holler E, Finke JM: Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies. Blood, 2008; 112 (2): 415-425.
  • Otte A: Does health economics have an impact on non-Hodgkin's lymphoma patients' options? Nucl Med Commun, 2008; 29: 748-750.
  • Otte A: Diagnostic imaging prior to 90Y-ibritumomab tiuxetan (Zevalin®) treatment in follicular non-Hodgkin’s lymphoma hellenic Journal of Nuclear Medicine, 2008; 11 (1): 12-15.
  • Otte A, Rosé C, Zähringer A, Maier-Lenz H: Neue klinische Technologien in der Arzneimittelentwicklung Internist, 2008; 49: 232-237.
  • Quanjer P H, Borsboom G J J M, Kivastik Jana, Merkus P J F M, Hankinson J L, Houthuijs D, Brunekreef B, Ihorst G, Kühr J: Cross-sectional and Longitudinal Spirometry in Children and Adolescents: Interpretative Strategies. Am J Resp Crit Care, 2008; 178: 1262-1270.
  • Revencu N, Boon L, Mulliken J, Enjolras O, Cordiscso M, Burrows P, Clapuyt P, Hammer F, Dubois J, Baselga E, Brancati F, Carder R, Quintal J, Dallapiccola B, Fischer G, Frieden I, Garzon M, Harper J, Johnson-Patel J, Labrèze C, Martorell L, Paltiel H, Pohl A, Prendiville J, Quere I, Siegel D, Valente W, Hagen van A, Hest van L, Vaux K, Vicente A, Weibel L, Chitayat D, Vikkula M: Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations Hum Mutat, 2008; 29 (7): 959-965.
  • Schmoor C, Caputo A, Schumacher M: Evidence from Nonrandomized Studies: A Case Study on the Estimation of Causal Effects Am J Epidemiol, 2008; 167 (9): 1120-1129.
  • Silberer J, Ihorst G, Kopp M V: Cytokine levels in supernatants of whole blood and mononuclear cell cultures in adults and neonates reveal significant differences with respect to interleukin-13 and interferon-gamma Pediatric Allergy and Immunology, 2008; 19 (2): 140-147.
  • Wasem S, Weichert S, Walther S, Weigl J A, Puppe W, Ihorst G, Schmitt H J, Forster J: Lower Respiratory Tract Disease in Children: Constant Pathogens - Constant Management?! Untere Atemwegsinfektionen bei Kindern: Gleiche Erreger - immer die gleiche Behandlung?! Klin Padiatr, 2008; 220: 291-295.
  • Wink K, Otte A: Können durch eine "Superpille" Herz-Kreislauf-Krankheiten um über 8o% vermindert werden? Ubersicht über die epidemiologische Studie von Wald und Law aus dem Jahr 2003. Can cardiovascular diseases be reduced over 80% by a "superpill"? Review on the epidemiological study from Wald and Law, 2003 Münchner Medizinische Wochenschrift - Fortschritte der Medizin 2007, 2008; 4 (149): 148-152.
  • Zander A, Schmoor C, Kröger N, Krüger W, Möbus V, Frickhofen N, Metzner B, Berdel W, Koenigsmann M, Thiel E, Wandt H, possinger K, Kreienberg R, Schumacher M, Jonat W: Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up Ann Oncol, 2008; 19: 1082-1089.
  • Engelhardt M, Zeiser R, Ihorst G, Finke J, Müller CI: High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma. J Cancer Res Clin, 2007; 133: 1-11.
  • Ihorst G, Forster J, Petersen G, Werchau H, Rohwedder A, Schumacher M: The use of imperfect diagnostic tests had an impact on prevalence estimation. J Clin Epidemiol, 2007; 60: 902-910.
  • Kleber M, Cybulla M, Bauchmüller K, Ihorst G, Koch B, Engelhardt M: Monitoring of renal function in cancer patients: an ongoing challenge for clinical practice. Ann Oncol, 2007; 18: 950-958.
  • Müller C, Caputo A, Schumacher M, Raab G, Schütte M, Hilfrich J, Kaufmann M, von Minckwitz G: Clinical response by palpation during primary systemic therapy with four dose-dense cycles doxorubicin and docetaxel in patients with operable breast cancer: Further results from a randomised controlled trial. Eur J Cancer, 2007; 43 (11): 1654-1661.
  • Otte A: Arzneimitteltestung am Menschen: Die Risiken im Licht der Katastrophe von London. Internist, 2007; 48: 636-641.
  • Sauerland D, Otte A: Professionalisierung der Klinischen Forschung in Deutschland durch neuen Masterstudiengang. Deutsche Zeitschrift für Klinische Forschung (DZKF), 2007; 11 (7-8): 71-72.
  • Sauerland D, Otte A: Professionalisierung der Klinischen Forschung in Deutschland durch neuen Masterstudiengang. Baden-Württembergisches Ärzteblatt, 2007; 8: 410-411.
  • Schauer U, Ihorst G, Rohwedder A, Petersen G, Berner R, Frank HD, Forster J, Stephan V: Evaluation of Respiratory Syncytial Virus Detection by Rapid Antigen Tests in Childhood. Klin Padiatr, 2007; 219: 212-216.
  • Strobel ES, Bauchmüller K, Ihorst G, Engelhardt M: Frequency, severity and risk factors for oral mucositis after BEAM conditioning and autologous peripheral blood stem cell transplantation: A single center analysis and review of the literature. Leukemia Lymphoma, 2007; 48: 2255-2260.
  • Wink K, Otte A, Erbel R: Todesursache Nummer Eins Herz-Kreislauferkrankungen. Netzwerk der Koordinierungszentren für klinische Studien unterstützt Fortschritt in kardiovaskulärer Forschung. Deutsche Zeitschrift für Klinische Forschung (DZKF), 2007; 11 (5/6): 52-56.
  • Zlei M, Egert S, Wider D, Ihorst G, Wäsch R, Engelhardt M: Characterization of in vitro growth of multiple myeloma cells. Exp Hematol, 2007; 35: 1550-1561.
  • Bertinetti C, Zirlik K, Heining-Mikesch K, Ihorst G, Dierbach H, Waller CF, Veelken H: Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression. Cancer Res, 2006; 66 (8): 4496-4502.
  • Duchniewicz M, Zemojtel T, Kolanczyk M, Grossmann S, Scheele JS, Zwartkruis FJ: Rap1A-deficient T and B cells show impaired integrin-mediated cell adhesion. Mol Cell Biol, 2006; 26 (2): 643-653.
  • Engelhardt M, Ihorst G, Behringer D, Finke J, Roth B: Incidence of monoclonal B-cell disease in siblings of patients with multiple myeloma. Haematol-hematol J, 2006; 91 (2): 274-276.
  • Feltgen N, Neubauer A, Jurklies B, Schmoor C, Schmidt D, Wanke J, Maier-Lenz H, Schumacher M: Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 : EAGLE Study report no. 1. Graef Arch Clin Exp, 2006; 244 (8): 950-956.
  • Haas PS, Bauchmuller K, Kuhnemund A, Finke J, Ihorst G, Engelhardt M: Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period. Ann Hematol, 2006; 85 (3): 191-193.
  • Illerhaus G, Marks R, Ihorst G, Guttenberger R, Ostertag C, Derigs G, Frickhofen N, Feuerhake F, Volk B, Finke J: High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma. J Clin Oncol, 2006; 24 (24): 3865-3870.
  • Kaiser S, Kagi D, Ihorst G, Kapp U: Perforin-independent rejection of transplanted human stem cells. Clin Exp Immunol, 2006; 145 (2): 332-338.
  • Kroger N, Milde-Langosch K, Riethdorf S, Schmoor C, Schumacher M, Zander AR, Loning T: Prognostic and predictive effects of immunohistochemical Factors in High-Risk Primary Breast Cancer Patients Clin Cancer Res, 2006; 12 (1): 159-168.
  • Muller AM, Ihorst G, Waller CF, Dolken G, Finke J, Engelhardt M: Intensive chemotherapy with autologous peripheral blood stem cell transplantation during a 10-year period in 64 patients with germ cell tumor. Biol Blood Marrow Tr, 2006; 12 (3): 355-365.
  • müller c, boeker m, classen j, klar r, lutterbach j: OncoCase: Fallbasiertes Lernen in der Neuro-Onkologie. GMS Z Med. Ausbildung, 2006; 23 (1) (online). : http://www.egms.de/en/journals/zma/2006-23/zma000226.shtml
  • Otte A: 90Y-Ibritumomab tiuxetan: new drug, interesting concept, and encouraging in practice. Nucl Med Commun, 2006; 27 (7): 595-596.
  • Otte A, Halsband U: Brain imaging tools in neurosciences. J Physiol-paris, 2006; 99 (4-6): 281-292.
  • Otte A, Thompson SL: Practical and clinical benefits of radioimmunotherapy lead to advantages in cost-effectiveness in the treatment of patients with non-Hodgkin's lymphoma. Nucl Med Commun, 2006; 27 (10): 753-756.
  • van der Hoek L, Sure K, Ihorst G, Stang A, Pyrc K, Jebbink MF, Petersen G, Forster J, Berkhout B, Uberla K: Human coronavirus NL63 infection is associated with croup. Adv Exp Med Biol, 2006; 581: 485-491.
  • Dreier G, Marx C, Schmoor C, Maier-Lenz H: [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2005; 48 (4): 445-452.
  • Dreier G, Marx C, Schmoor C, Maier-Lenz H: [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2005; 48 (4): 445-452.
  • Dreier G, Marx C, Schmoor C, Maier-Lenz H: [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2005; 48 (4): 445-452.
  • Ehlken B, Ihorst G, Lippert B, Rohwedder A, Petersen G, Schumacher M, Forster J: Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur J Pediatr, 2005; 164 (10): 607-615.
  • Elsasser-Beile U, Leiber C, Wolf P, Lucht M, Mengs U, Wetterauer U: Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract. J Urology, 2005; 174 (1): 76-79.
  • Feltgen N, Neubauer A, Jurklies B, Schmoor C, Schmidt D, Wanke J, Maier-Lenz H, Schumacher M: Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 EAGLE Study report no. 1. Graef Arch Clin Exp, 2005 (online): 1-7.
  • Kopp MV, Semmler S, Ihorst G, Berner R, Forster J: Hospital admission with neonatal sepsis and development of atopic disease: Is there a link? Pediatr Allergy Immu, 2005; 16 (8): 630-636.
  • Muller AM, Ihorst G, Mertelsmann R, Engelhardt M: Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol, 2005; 84 (1): 1-12.
  • Otte A, Dierckx RA: Myelosuppressive side-effects of radioimmunotherapy of non-Hodgkin's lymphoma: is there an increased risk? Nucl Med Commun, 2005; 26 (12): 1045-1047.
  • Otte A, Maier-Lenz H, Dierckx RA: Good clinical practice: Historical background and key aspects. Nucl Med Commun, 2005; 26 (7): 563-574.
  • Spyridonidis A, Bertz H, Ihorst G, Grullich C, Finke J: Hematopoietic cell transplantation from unrelated donors as an effective therapy for older patients (> or = 60 years) with active myeloid malignancies. Blood, 2005; 105 (10): 4147-4148.
  • Stiglmayr CE, Grathwol T, Linehan MM, Ihorst G, Fahrenberg J, Bohus M: Aversive tension in patients with borderline personality disorder: a computer-based controlled field study. Acta Psychiat Scand, 2005; 111 (5): 372-379.
  • van der Hoek L, Sure K, Ihorst G, Stang A, Pyrc K, Jebbink MF, Petersen G, Forster J, Berkhout B, Uberla K: Croup is associated with the novel coronavirus NL63. Public Library of Sciences Medicine, 2005; 2 (8): e240-e240.
  • Zeiser R, Spyridonidis A, Wasch R, Ihorst G, Grullich C, Bertz H, Finke J: Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation. Leukemia, 2005; 19 (5): 814-821.
  • Antes G, Augustin N, Beyersmann J, Caputo A, Falck-Ytter Y, Gerds T, Gerlach A, Graf E, Hollaender N, Ihorst G, Lang B, Meier-Hirmer C, Musio M, Olschewski M, Roßner R, Sauerbrei J, Schlingmann J, Schmoor C, Schulgen G, Schulte Moenting J, Schwarzer G, Schumacher M: Freiburger Beitraege zur Biometrie und Klinischen Epidemiologie Informatik, Biometrie und Epidemiologie in Medizin und Biologie, 2004; 35 (2): 74-122.
  • Dreier G, Cichutek K: Das Deutsche Register für somatische Gentransferstudien - DeReG Bundesgesundheitsblatt, 2004; 6: 554-558.
  • Forster J, Ihorst G, Rieger CH, Stephan V, Frank HD, Gurth H, Berner R, Rohwedder A, Werchau H, Schumacher M, Tsai T, Petersen G: Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). Eur J Pediatr, 2004; 163: 709-716.
  • Horak F Jr, Matthews S, Ihorst G, Arshad SH, Frischer T, Kuehr J, Schwieger A, Forster J: Effect of mite-impermeable mattress encasings and an educational package on the development of allergies in a multinational randomized, controlled birth-cohort study -- 24 months results of the Study of Prevention of Allergy in Children in Europe. Clin Exp Allergy, 2004; 34 (8): 1220-1225.
  • Ihorst G, Forster J, Petersen G, Schumacher M: Determination of the population size in an epidemiological study with children. Method Inform Med, 2004; 43 (5): 479-482.
  • Ihorst G, Frischer T, Horak F, Schumacher M, Kopp M, Forster J, Mattes J, Kuehr J: Long- and medium-term ozone effects on lung growth including a broad spectrum of exposure. Eur Respir J, 2004; 23 (2): 292-299.
  • Konig B, Konig W, Arnold R, Werchau H, Ihorst G, Forster J: Prospective study of human metapneumovirus infection in children less than 3 years of age. J Clin Microbiol, 2004; 42 (10): 4632-4635.
  • Storm Van's Gravesande K, Mattes J, Endlicher A, Alving K, Ihorst G, Kuhr J: [Effect of two doses of budesonide on exhaled nitric oxide and urinary EPX excretion in asthmatic children] Pneumologie, 2004; 58 (7): 483-488.
  • Struck A, Forster J, Ihorst G, Werchau H, Konig W, Konig B: Respiratory syncytial virus: G gene genotype and disease severity. Pediatr Infect Dis J, 2004; 23 (11): 1000-1002.
  • Winzer KJ, Sauer R, Sauerbrei W, Schneller E, Jaeger W, Braun M, Dunst J, Liersch T, Zedelius M, Brunnert K, Guski H, Schmoor C, Schumacher M, German Breast Cancer Study Group: Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence. European Journal of Cancer, 2004; 40 (7): 998-1005.
  • Zander AR, Kroger N, Schmoor C, Kruger W, Mobus V, Frickhofen N, Metzner B, Schultze W, Berdel WE, Koenigsmann M, Thiel E, Wandt H, Possinger K, Trumper L, Kreienberg R, Carstensen M, Schmidt EH, Janicke F, Schumacher M, Jonat W: High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial. Journal of Clinical Oncology, 2004; 22 (12): 2273-2283.
  • Behringer B, Pitako JA, Kunzmann R, Schmoor C, Behringer D, Mertelsmann R, Lubbert M: Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective study. Annals of Hematology, 2003; 82 (7): 381-389.
  • Deibert P, Dilger K, Fischer C, Hofmann U, Nauck S, Stoelben S, Kreisel W: High variation of tioguanine absorption in patients with chronic active Crohn's disease. Aliment Pharm Therap, 2003; 18 (2): 183-189.
  • Finke J, Schmoor C, Lang H, Potthoff K, Bertz H: Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin. Journal of Clinical Oncology, 2003; 21 (3): 506-513.
  • Kopp MV, Mayatepek E, Engels E, Brauburger J, Riedinger F, Ihorst G, Wahn U, Kuehr J: Urinary leukotriene E4 levels in children with allergic rhinitis treated with specific immunotherapy and anti-IgE (Omalizumab). Pediatr Allergy Immu, 2003; 14 (5): 401-404.
  • Luebbert M, Kunzmann R, Schmoor C, Behringer D, Mertelsmann R, Behringer B: Single-Center Retrospective Analysis of Prognosis of 138 Patients Older than 55 Years with Acute Myeloid Leukemia Ann Hematol, 2003; 41: 312-321.
  • Maier-Lenz H: Erfassung, Bewertung und Berichtung unerwünschter Wirkungen von Arzneimitteln Nieren- und Hochdruckkrankheiten, 2003; 32 (2): 89-90.
  • Maier-Lenz H: [Clinical trials in Germany: steadily progressing!] Deut Med Wochenschr, 2003; 128 (38): 1939-1940.
  • Strauch E, Moske O, Thoma S, Storm Van's Gravesande K, Ihorst G, Brandis M, Kuehr J: A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma. Pediatr Res, 2003; 54 (2): 198-203.
  • Sykes DB, Scheele J, Pasillas M, Kamps MP: Transcriptional profiling during the early differentiation of granulocyte and monocyte progenitors controlled by conditional versions of the E2a-Pbx1 oncoprotein. Leukemia Lymphoma, 2003; 44 (7): 1187-1199.
  • Zahradnik H P, Wetzka B, Schmoor C, Stoelben S, Karck U, Jahn A, Diergarten K, Maier-Lenz H: Prospektive, offene multizentrische Phase-IV-Studie zur Wirksamkeit und Verträglichkeit von Tibolon bei postmenopausalen Beschwerden Journal für Menopause, 2003; 10 (1): 28-34.
  • Zemojtel T, Scheele JS, Martasek P, Masters BS, Sharma VS, Magde D: Role of the interdomain linker probed by kinetics of CO ligation to an endothelial nitric oxide synthase mutant lacking the calmodulin binding peptide (residues 503-517 in bovine). Biochemistry, 2003; 42 (21): 6500-6506.
Reviews/Übersichtsartikel in wissenschaftlichen Fachzeitschriften:
  • Hasselblatt H, Jena S, Antes G, Dreier G: Deutsches Register Klinischer Studien. Eine zusätzliche Quelle für Arzneimittelinformationen. In: , editors. Deutscher Apothekerverlag, 2012; 33 (3): 121-125.
  • Otte A, Wiele C, Dierckx R A: Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next step nucl med commun, 2009; 30: 5-15.
  • Schmoor C: Introduction to Randomized Controlled Clinical Trials. By J. N. S. Matthews Biometrical J, 2008; 50: 451-451.
  • Wink K, Otte A: Können durch eine „Superpille“ Herz-Kreislauf-Krankheiten um über 80% vermindert werden? Übersicht über die epidemiologische Studie von Wald und Law aus dem Jahr 2003. MMW-Fortschritte der Medizin, 2007; 149 (IV): 148-152.
Monographien:
  • Beyersmann J, Allignol A, Schumacher M: Competing Risks and Multistate Models with RSpringer Verlag, 2012. : http://www.springer.com/statistics/statistical+theory+and+methods/book/978-1-4614-2034-7
  • Otte A: Angewandte klinische Forschung II: Medical Writing. , Lahr: WHL Wissenschaftliche Hochschule Lahr, 2007 (Studienbuch für den Masterstudiengang Clinical Research Management.).
  • Otte A: Angewandte klinische Forschung II: Neue klinische Technologien in der Medikamentenentwicklung (Clinical Technologies Implementation), Lahr: WHL Wissenschaftliche Hochschule Lahr, 2007 (Studienbuch für den Masterstudiengang Clinical Research Management.).
  • Otte A: Grundlagen der klinischen Forschung I: Clinical Research Terminologie, Definitionen und Einrichtungen, Lahr: WHL Wissenschaftliche Hochschule Lahr, 2007.
  • Otte A: Grundlagen der klinischen Forschung II: Klinische Studien mit ionisierenden Strahlen (StrSchV, RöV), Lahr: WHL Wissenschaftliche Hochschule Lahr, 2007 (Studienbuch für den Masterstudiengang Clinical Research Management.).
  • Otte A: Grundlagen der klinischen Forschung I: Good Clinical Practice (GCP): Historische Entwicklung und wesentliche Aspekte, Lahr: WHL Wissenschaftliche Hochschule Lahr, 2007 (Studienbuch für den Masterstudiengang Clinical Research Management.).
  • Otte A: Medizin für Nicht-Mediziner: Geschichte der Medizin, Lahr: WHL Wissenschaftliche Hochschule Lahr, 2007 (Studienbuch für den Masterstudiengang Clinical Research Management.).
  • Otte A: Medizin für Nicht-Mediziner: Medizintechnik, Lahr: WHL Wissenschaftliche Hochschule Lahr, 2007 (Studienbuch für den Masterstudiengang Clinical Research Management.).
  • Otte A, Wink K: Kerners Krankheiten großer Musiker. Die Neubearbeitung , Stuttgart: Schattauer, 6. erw. Auflage, 2007.
Buchbeiträge:
  • Dreier G, Jena S: Registrierung klinischer Studien In: Christian Lenk, Gunnar Duttge, Heiner Fangerau (Hrsg.): Handbuch Ethik und Recht der Forschung am Menschen Berlin - Heidelberg: Springer-Verlag, 2014; 643-648.: http://www.springer.com/gp/book/9783642350986
  • Schmoor C, Graf E: Hazard Ratio. In: Balakrishnan N (Hrsg.): Methods and Applications of Statistics in Clinical Trials, Volume 1: Concepts, Principles, Trials, and Designs. Hoboken, New Jersey: John Wiley & Sons, 2014; 483-499.: http://dx.doi.org/10.1002/9781118596005.ch38
  • Gäbler I, Gerlach A, Kaufmann M: Datenmanagement in klinischen Studien In: Schumacher M, Schulgen G (Hrsg.): Methodik Klinischer Studien - Methodische Grundlagen der Planung, Durchführung und Auswertung Berlin - Heidelberg: Springer-Verlag, 2008; 221-243.
  • Otte A: Langzeitfolgen des HWS-Schleudertraumas. Neue Aspekte der funktionellen Bildgebung In: Graf M, Grill C, Wedig HD (Hrsg.): Beschleunigungsverletzung der Halswirbelsäule Darmstadt: Springer Steinkopff Verlag, 2008; 184-195.
  • Schmoor C: Die Problematik von Subgruppenanalysen in klinischen Studien: Eine hypothetische klinische Studie beim Mammakarzinom. In: Schumacher M, Schulgen G (Hrsg.): Methodik Klinischer Studien - Methodische Grundlagen der Planung, Durchführung und Auswertung Berlin - Heidelberg: Springer-Verlag, 2008; 355-367.
  • Schmoor C, Stoelben S, Maier-Lenz H, Berger D, Henß H: Drug Development and Clinical Studies In: Berger D.P., Engelhardt M., Henß H., Mertelsmann R. (Hrsg.): Concise Manual of Hematology and Oncology Freiburg: Springer-Verlag, 2008; 198-200.
  • Schulgen G, Schmoor C: Randomisation und Verblindung In: Schumacher M, Schulgen G (Hrsg.): Methodik Klinischer Studien - Methodische Grundlagen der Planung, Durchführung und Auswertung Berlin - Heidelberg: Springer-Verlag, 2008; 195-205.
  • Schulgen G, Schmoor C: Randomisation und Verblindung In: Schumacher M, Schulgen G (Hrsg.): Methodik Klinischer Studien - Methodische Grundlagen der Planung, Durchführung und Auswertung Berlin - Heidelberg: Springer-Verlag, 2008; 195-205.
  • Schumacher M, Schmoor C: Zur Notwendigkeit randomisierter Studien: Hochdosis-Chemotherapie beim Mammakarzinon In: Schumacher M, Schulgen G (Hrsg.): Methodik Klinischer Studien - Methodische Grundlagen der Planung, Durchführung und Auswertung Berlin - Heidelberg: Springer-Verlag, 2008; 21-29.
  • Schumacher M, Schmoor C: Analyse von Ereigniszeiten - Teil II. In: Schumacher M, Schulgen G (Hrsg.): Methodik Klinischer Studien - Methodische Grundlagen der Planung, Durchführung und Auswertung Berlin - Heidelberg: Springer-Verlag, 2008; 95-111.
  • Müller C, Boeker M, Klar R, Lutterbach J: OncoCase: Fallbasiertes Lernen in der Neuroonkologie. In: Universitätsbibliothek Freiburg (Hrsg.): Neue Medien als strategische Schrittmacher an der Universität Freiburg - wie Informations- und Kommunikationstechnologien Verwaltung, Lehre und Forschung verändern. Freiburg: Universitätsbibliothek Freiburg, 2007; 195-205.
  • Schmoor C: Die Problematik von Subgruppenanalysen in klinischen Studien: Eine hypothetische klinische Studie beim Mammakarzinom. In: Schumacher M, Schulgen G (Hrsg.): Methodik Klinischer Studien - Methodische Grundlagen der Planung, Durchführung und Auswertung, 2. Auflage. Berlin - Heidelberg - New York: Springer-Verlag, 2007; 355-367.
  • Schmoor C, Schumacher M: Zur Notwendigkeit randomisierter Studien: Hochdosis-Chemotherapie beim Mammakarzinom. In: Schumacher M, Schulgen G (Hrsg.): Methodik Klinischer Studien - Methodische Grundlagen der Planung, Durchführung und Auswertung, 2. Auflage. Berlin - Heidelberg - New York: Springer-Verlag, 2007; 21-29.
  • Schulgen G, Schmoor C: Randomisation und Verblindung. In: Schumacher M, Schulgen G (Hrsg.): Methodik Klinischer Studien - Methodische Grundlagen der Planung, Durchführung und Auswertung, 2.. Auflage. Berlin - Heidelberg - New York: Springer-Verlag, 2007; 195-205.
  • Schumacher M, Schmoor C: Analyse von Ereigniszeiten - Teil II. In: Schumacher M, Schulgen G (Hrsg.): Methodik Klinischer Studien - Methodische Grundlagen der Planung, Durchführung und Auswertung, 2. Auflage. Berlin - Heidelberg - New York: Springer-Verlag, 2007; 95-112.
  • Seiler CM, Bruns I, Wolff S, Lehmacher W, Löffler M, Maier-Lenz H: Das Netzwerk der Koordinierungszentren für Klinische Studien. In: R. Kunz, G. Ollenschläger, H. Raspe, G. Jonitz, N. Donner-Banzhoff (Hrsg.): Lehrbuch Evidenz-basierte Medizin in Klinik und Praxis, 2. Auflage. Köln: Deutscher Ärzte-Verlag, 2007; 467-474.
  • seiler cm, bruns i, wolff s, lehmacher w, löffler m, maier-lenz h: Das Netzwerk der Koordinierungszentren für Klinische Studien In: EbM-Lehrbuch Deutscher Ärzte Verlag, 2006.
  • Berger DP, Scheele JS, Engelhardt R: Charakterisierung klinisch eingesetzter Zytostatika In: Berger DP, Engelhardt R, Mertelmann R (Hrsg.): Das Rote Buch, 3. Auflage. Landsberg: ecomed, 2004; 52-110.
  • Martens U, Müller A, Scheele JS: Pharmakogenetik und Pharmakogenomik In: Berger DP, Engelhardt R, Mertelmann R (Hrsg.): Das Rote Buch, 3. Auflage. Landsberg: econ, 2004; 349-351.
  • Potthoff K, Waesch R, Berger DP, Scheele JS: Spezifische Inhibitoren ("Targeted Therapies" In: Berger DP, Engelhardt R, Mertelmann R (Hrsg.): Das Rote Buch, 3. Auflage. Landsberg: econ, 2004; 154-158.
  • Scheele JS, Berger DP: Angiogenesehemmung In: Berger DP, Engelhardt R, Mertelmann R (Hrsg.): Das Rote Buch, 3. Auflage. Landsberg: econ, 2004; 342-345.
  • Scheele JS, Berger DP, Engelhardt R: Tumoren von Gallenblase und Gallenwegen In: Berger DP, Engelhardt R, Mertelmann R (Hrsg.): Das Rote Buch, 3. Auflage. Landsberg: econ, 2004; 622-625.
  • Scheele JS, Martens U: Globale Genexpressionsanalysen In: Berger DP, Engelhardt R, Mertelmann R (Hrsg.): Das Rote Buch, 3. Auflage. Landsberg: econ, 2004; 345-348.
Kurzbeiträge / short communications:
  • Ihorst G, Waldschmidt J, Schumacher M, Wäsch R, Engelhardt M: Analysis of survival by tumor response: have we learnt any better? Ann Hematol, 2015; 94 (9): 1615-1616. : http://dx.doi.org/10.1007/s00277-015-2426-8
  • Kirschner J, Ihorst G, Korinthenberg R: Measuring muscle strength in clinical trials — Authors' reply Lancet Neurol, 2010; 9: 1146-1147. : http://dx.doi.org/10.1016/S1474-4422(10)70286-6
  • Rücker G, Graf E, Schumacher M: Letter to the editor concerning Shadish WR, Clark MH, Steiner PM: Can Nonrandomized Experiments Yield Accurate Answers? A Randomized Experiment Comparing Random and Nonrandom Assignments. Journal of the American Statistical Association. December 1, 2008, 103(484): 1334-1344. doi:10.1198/016214508000000733. [Website: http://pubs.amstat.org/doi/abs/10.1198/016214508000000733] J Am Stat Assoc, 2010 (online): 1-6. : http://pubs.amstat.org/doi/suppl/10.1198/016214508000000733/suppl_file/Letter.pdf
  • Grass G, Maier-Lenz H, Haerting J, Otte A: Ethik-Kommission: Aus Erfahrung (Brief zu:) "Arbeitskreis medizinischer Ethik-Kommissionen: Schulung für Prüfärzte in der Diskussion". Deutsches Ärzteblatt, 2008; 105 (43): 28-29.
  • Schmoor C, Schumacher M: Adequate adjustment for confoudners is vital for a valid interpretation of meta-analyses incorporating non randomized studies Z Evid Fortbild Qual Gesundh wesen, 2008; 102: 70-71.
  • Otte A: Hybrid imaging: Which road to go? Hell J Nucl Med, 2007; 10 (3): 181.
Vorträge:
  • Marx C: Investigator Initiated Trials (IITs). Unterstützung des Prüfarztes/Investigatorsponsors aus der Sicht eines ZKS (KKS) 2007 (CESAR-Symposium Juni 2007 Freiburg).
  • Otte A: Cost-effectiveness and QoL aspects of the use of Zevalin®. 2007 (International Meeting on 90Y-Ibritumomab Tiuxetan use in lymphoma patients. Milan, 09.03.2007.).
  • Otte A: Neue klinische Technologien für die Arzneimittelentwicklung. 2007 (2. KKS-Netzwerk-Symposium: Klinische Studien in Europa / Clinical Trials in Europe. Köln, 9.-10.11.2007.).
  • Zähringer A: ICH-GCP Allgemeine Einführung. 2007 (14. Basiskurs Studienassistent/in 12./13.10.2007. Zentrum Klinische Studien. Albert-Ludwigs-Universität Freiburg).
  • Zähringer A: ICH-GCP, EU-GCP, Studienteams. 2007 (7. Aufbaukurs Studienassistent/in 05./06.07.2007. Zentrum Klinische Studien, Albert-Ludwigs-Universität Freiburg.).
  • Zähringer A: ICH-GCP, EU-GCP, Studienteams. 2007 (8. Aufbaukurs für Studienassistent/in 25./26.10.2007. Zentrum Klinische Studien, Albert-Ludwigs-Universität Freiburg.).
  • Zähringer A: Begriffsbestimmungen, Ethik und Recht Teil I und II. 2007 (Curriculum Prüfarzt/ -ärztin 06./07.12.2007. Zentrum Klinische Studien, Albert-Ludwigs-Universität Freiburg.).
  • Zähringer A: Begriffsbestimmungen, Ethik und Recht Teil I und II. 2007 (Curriculum Prüfarzt/ -ärztin 29./30.11.2007. Zentrum Klinische Studien, Albert-Ludwigs-Universität Freiburg.).
  • Zähringer A: Ethik und Recht Teil I und II. 2007 (Curriculum Prüfarzt/ -ärztin 01./02.03.2007. Zentrum Klinische Studien, Albert-Ludwigs-Universität Freiburg.).
  • Dreier G: Register klinischer Studien - ein Beitrag für mehr Qualität, Transparenz und Patientensicherheit 2005 (12. Jahrestagung der GQMG (Gesellschaft für Qualitätsmanagement in der Gesundheitsforschung e.V.)).
  • Dreier G: The need for Clinical Trial databases 2005 (12th Annual Meeting of the German Society of Gene Therapy).
  • Maier-Lenz H: Aufgaben und Hilfestellung der Koordinierungszentren für Klinische Studien im Rahmen Prüfer-initiierter Studien 2005 (BfArM im Dialog, "Klinische Prüfungen / GCP").
Konferenzbeiträge:
  • Fuellgraf H, Haug S, Kiefer S, Schmid S, Wang Y, Schneider D, Boeker M, Bredenkamp R, Bronsert P, Werner M: Implementation of Automised Import of Patient Consent Form for Biobanking 101. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V., 2017; A-526 (101. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V.).
  • Koehler M, Surlan I, Schulz A, Altindis-Guerlue M, Angerer R, Bierenstiel S, Bubritzki S, Falahen M, Hoefflin M, Jakobs D, Kappes S, Karaaslan C, Meisenzahl J, Messner C, Pfaller S, Singer N, Souchon S, Ullrich A, Wenske S, Wisser B, Kiote-Schmidt C, Rummelt C, Schnerch D, Dorn F, Rettig A, Ajayi S, Otte P, Reinhardt H, Szymaniak-Vits M, Bertz H, von Bubnoff N, Dierks C, Finke J, Fritsch R, Heinz J, Luebbert M, Marks R, Rawluk J, Waller C, Zeiser R, Ruch M, Boeker M, Bredenkamp R, Duyster J, Waesch R, Illerst L, Engelhardt M: Early Clinical Trial Unit (ECTU) and entire Clinical Trial (CT) activities in hematology & oncology (H&O) supported by the Clinical Cancer Research (CCR-) Group and Comprehensive Cancer Center (CCCF) role model for others Oncol Res Treat, 2017.
  • Blagitko-Dorfs N, Schlosser P, Claus R, Ma T, Ziegler R, Götze K, Heuser M, Heil G, Wessendorf S, Neubauer A, Krauter J, Dresel I, Döhner K, Bug G, Lindemann HW, Salih HR, Scholl S, Müller-Tidow C, Brugger W, Crysandt M, Egger M, Germing U, Lange E, Giagounidis A, Grishina O, Hackanson B, Schumacher M, Lübbert M: Transient in vivo DNA demethylation in peripheral blood blasts of AML patients treated with Decitabine. Abstract V714. Oncol Res Treat, 2015; 38 Suppl. 5: 213-214 (Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie Basel, 9.-13. Oktober 2015). : http://www.karger.com/Article/FullText/439070#V714
  • Graziani G, Waldschmidt J, Herget GW, Pandurevic M, Henne K, Selder R, May AM, Möller M, Ihorst G, Thomsen A, Reinhardt H, Vach W, Duyster J, Wäsch R, Engelhardt M: Are we at our best to avoid delays in diagnosis finding: Assessment of time from onset of first symptoms to the final diagnosis of multiple myeloma - possible risks and future solutions. Abstract P785. Oncol Res Treat, 2015; 38 Suppl. 5: 239 (Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie Basel, 9.-13. Oktober 2015). : http://www.karger.com/Article/FullText/439070#P785
  • Promny I, Hieke S, Schinke M, Waldschmidt J, Ihorst G, Pantic M, Duyster J, Wäsch R, Schumacher M, Engelhardt M: Conditional survival (CS) in Multiple Myeloma (MM) provides detailed prognostic information of outcome in a large MM data set. Abstract P775. Oncol Res Treat, 2015; 38 Suppl. 5: 235 (Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie Basel, 9.-13. Oktober 2015). : http://www.karger.com/Article/FullText/439070#P775
  • Selder RM, Möller MD, Pandurevic M, Waldschmidt J, Ihorst G, Herget GW, Henne K, Hauschild O, May AM, Pantic M, Duyster J, Vach W, Mäsch R, Engelhardt M: Results of the interdisciplinary Comprehensive Cancer Center Freiburg (CCCF) Tumor Board (TB)-'Multiple Myeloma' (MM) in terms of TB-recommendations, patient (pt) outcome, inclusion of difficult-to-treat-MM pts in clinical trials (CT) and satisfaction of patients, participants and referring physicians. Abstract P774. Oncol Res Treat, 2015; 38 Suppl. 5: 234-235 (Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie Basel, 9.-13. Oktober 2015). : http://www.karger.com/Article/FullText/439070#P774
  • Zober A, Hieke S, Ihorst G, Pantic M, Duyster J, Schumacher M, Mäsch R, Engelhardt M: Prospective assessment of a comorbidity and functional geriatric assessment (CF-GA), including the revised Freiburg Comorbidity Index (rFCI) in consecutive elderly MM patients (pts). Abstract P776. Oncol Res Treat, 2015; 38 Suppl. 5: 235-236 (Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie Basel, 9.-13. Oktober 2015). : http://www.karger.com/Article/FullText/439070#P776
  • Domm AS, Kleber M, Hieke S, Schumacher M, Ihorst G, Koch B, Duyster J, Waesch R, Engelhardt M: Comprehensive assessment of comorbidities (CM), general condition and multiple myeloma (MM)specific risk factors (RF) within a refined Freiburg Comorbidity Index (rFCI) in 803 consecutive MM patients (pts) and comparison with established comorbidity indices. (Meeting Abstract: V71). Oncology Research and Treatment, 2014; 37 Suppl. 5: 19 (Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Hamburg, 10.-14. Oktober.). : http://dx.doi.org/10.1159/000368945
  • Hackanson, B, Schmoor, C, Bertz, H, Marks, R, Waesch, R, Zeiser, R, Finke, J: Long-term follow-up of therapy-related MDS and AML patients treated with allogeneic hematopoietic cell transplantation reveals substantial 10 years survival and comparably low treatment-related mortality. Blood, 2014; 124: 1264 (ASH Annual Meeting Abstracts).
  • Selder R, Pandurevic M, Möller MD, Waldschmidt J, Pantic M, Herget GW, Henne K, May A, Kleber M, Udi J, Ihorst G, Bredenkamp R, Vach W, Duyster J, Wäsch R, Engelhardt M: First Results of the Interdisciplinary Comprehensive Cancer Center Freiburg (CCCF) Tumor Board (TB) Multiple Myeloma (MM) Assessing TB-Questions, TB-Advice Adherence, TB-Satisfaction of Patients, Participants and Referring Physicians, Inclusion of Difficult-to-Treat-MM Pts in Clinical Trials (CT) and Patient Outcome. Blood, 2014; 124 (21) (56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, Dec 06-09, 2014). : http://www.bloodjournal.org/content/124/21/2635
  • Wünsch A, de Figueiredo M, Gölz T, Ihorst G, Bertz H, Fritzsche K: Individualised communication skills training for randomised clinical trials in oncology. Final results of a RCT. Oncology Research and Treatment, 2014; 37 Suppl. 1: 27-28 (i-KON - intelligente Konzepte in der Onkologie. 31. Deutscher Krebskongress (DKK), Berlin, Februar 2014.). : http://dx.doi.org/10.1159/000360634
  • Müller K, Biller S, Pohl A, Müller C, Falck-Ytter Y, Forster J: Long-term effects of a standardized course in Evidence Based Medicine (EBM) 2007 (Association for Medical Education in Europe (AMEE), Trondheim).
  • Dreier G: Implementierung klinischer Studienregister - Erfahrung und Methodik am Beispiel eines nationalen und eines lokalen Registers im Vergleich 2005 (50. Jahrestagung GMDS (Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie)).
  • Dreier G, Lucht M, Peters R, Gossen G, Schumacher M, Maier-Lenz H: Implementierung und qualitätsgesicherte Pflege eines Registers klinischer Studien am Universitätsklinikum Freiburg - Status und Ergebnisse 2005 (50. Jahrestagung GMDS (Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie)).
  • Gerlach A, Kaufmann M, Roßner H: Entwicklung eines GCP konformen Datenmanagement Systems in SAS 2005 (9. KSFE (Konferenz der SAS-Anwender in Forschung und Entwicklung)).
  • Kaufmann M, Roßner H: Entwicklung eines GCP konformen Datenmanagement Systems in SAS 2005 (50. Jahrestagung GMDS (Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie)).
  • Marx C, Grichina O, Schober T, Kuchinke W, Rothe A, Dörschmann M, Beckmann C, Peters R, Maier-Lenz H: Klinische Studien: SAE-Management nach der 12. AMG-Novelle 2005 (50. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie).
  • Peters R, Dreier G, Gossen G, Schumacher M, Maier-Lenz H: Implementierung eines Registers Klinischer Studien am Universitätsklinikum Freiburg - technische Umsetzung als Voraussetzung für qualitätsgesicherte Daten zur Auswertung und Präsentation 2005 (50. Jahrestagung GMDS (Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie)).
  • Caputo A, Graf E, Schmoor C: Causal effect estimation in a partially randomized trial Biometrical J, 2004; 46 Suppl. 1: 11, Wiley Verlag GmbH & Co. KGaA (Hrsg).
  • Caputo A, Graf E, Schmoor C: Evidence from a partially randomized trial - a comparison of different approaches Control Clin Trials, 2003; 24: 97.
  • Schmoor C: Methodological Requirements in the Conduct of Clinical Trials Onkologie, 2003; 26 Suppl. 1: 49.
Sonstige Publikationen:
  • Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Muller TA, Hanke K, Taromi S, Apostolova P, Illert AL, Melchinger W, Duquesne S, Schmitt-Graeff A, Osswald L, Yan KL, Weber A, Tugues S, Spath S, Pfeifer D, Follo M, Claus R, Lubbert M, Rummelt C, Bertz H, Wasch R, Haag J, Schmidts A, Schultheiss M, Bettinger D, Thimme R, Ullrich E, Tanriver Y, Vuong GL, Arnold R, Hemmati P, Wolf D, Ditschkowski M, Jilg C, Wilhelm K, Leiber C, Gerull S, Halter J, Lengerke C, Pabst T, Schroeder T, Kobbe G, Rosler W, Doostkam S, Meckel S, Stabla K, Metzelder SK, Halbach S, Brummer T, Hu Z, Dengjel J, Hackanson B, Schmid C, Holtick U, Scheid C, Spyridonidis A, Stolzel F, Ordemann R, Muller LP, Sicre-de-Fontbrune F, Ihorst G, Kuball J, Ehlert JE, Feger D, Wagner EM, Cahn JY, Schnell J, Kuchenbauer F, Bunjes D, Chakraverty R, Richardson S, Gill S, Kroger N, Ayuk F, Vago L, Ciceri F, Muller AM, Kondo T, Teshima T, Klaeger S, Kuster B, Kim DDH, Weisdorf D, van der Velden W, Dorfel D, Bethge W, Hilgendorf I, Hochhaus A, Andrieux G, Borries M, Busch H, Magenau J, Reddy P, Labopin M, Antin JH, Henden AS, Hill GR, Kennedy GA, Bar M, Sarma A, McLornan D, Mufti G, Oran B, Rezvani K, Shah O, Negrin RS, Nagler A, Prinz M, Burchert A, Neubauer A, Beelen D, Mackensen A, von Bubnoff N, Herr W, Becher B, Socie G, Caligiuri MA, Ruggiero E, Bonini C, Hacker G, Duyster J, Finke J, Pearce E, Blazar BR, Zeiser R: Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med, 2018; 24 (4) : 526-526. : http://dx.doi.org/10.1038/nm0418-526c
  • Reinacher PC, Krueger MT, Coenen VA, Shah M, Roelz R, Jenkner C, Egger K: Reply. Am J Neuroradiol, 2017; 38 (12) : E106-E108. : http://dx.doi.org/10.3174/ajnr.A5386
  • Winter A, Hilgers RD, Hofestadt R, Hubner U, Knaup-Gregori P, Ose C, Schmoor C, Timmer A, Wege D: Good Medicine and Good Healthcare Demand Good Information (Systems). Method Inform Med, 2015; 54 (5) : 385-387. : http://dx.doi.org/10.3414/ME15-05-1001
  • Dreier G: Stellungnahme vor dem Deutschen Bundestag zum Gesetzentwurf: "Entwurf eines Vierzehnten Gesetzes zur Änderung des Arzneimittelgesetzes" - Stellungnahme Ausschussdrucksache 0868 (30) 2005.